Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 20, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-40624 | ||
Entity Registrant Name | CS Disco, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 46-4254444 | ||
Entity Address, Address Line One | 111 Congress Ave. | ||
Entity Address, Address Line Two | Suite 900 | ||
Entity Address, City or Town | Austin | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 78701 | ||
City Area Code | 833 | ||
Local Phone Number | 653-4726 | ||
Title of 12(b) Security | Common Stock, par value $0.005 | ||
Trading Symbol | LAW | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | true | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 413.9 | ||
Entity Common Stock, Shares Outstanding | 59,452,011 | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive Proxy Statement for the 2023 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2022. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001625641 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Auditor Information [Abstract] | |
Auditor Firm ID | 42 |
Auditor Name | Ernst & Young, LLP |
Auditor Location | Austin, Texas |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 203,244 | $ 255,477 |
Accounts receivable, net | 22,720 | 20,740 |
Other current assets | 5,576 | 4,634 |
Total current assets | 231,540 | 280,851 |
Property and equipment, net | 7,507 | 5,335 |
Operating lease right-of-use assets | 9,824 | 864 |
Intangible assets, net | 962 | 0 |
Goodwill | 5,898 | 0 |
Other assets | 591 | 351 |
Total assets | 256,322 | 287,401 |
Current liabilities: | ||
Accounts payable | 8,485 | 4,686 |
Accrued expenses | 4,705 | 2,844 |
Accrued salary and benefits | 3,536 | 7,955 |
Deferred revenue | 4,100 | 2,175 |
Operating leases | 1,902 | 890 |
Finance leases | 39 | 99 |
Total current liabilities | 22,767 | 18,649 |
Operating leases, non-current | 8,770 | 0 |
Finance leases, non-current | 199 | 0 |
Other liabilities | 950 | 75 |
Total liabilities | 32,686 | 18,724 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity | ||
Preferred stock $0.005 par value, 100,000 shares authorized and no shares issued and outstanding as of December 31, 2022 and 2021 | 0 | 0 |
Common stock $0.005 par value, 1,000,000 shares authorized as of December 31, 2022 and 2021; 59,190 and 58,010 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 296 | 291 |
Additional paid-in capital | 421,569 | 395,850 |
Accumulated deficit | (198,229) | (127,464) |
Total stockholders’ equity | 223,636 | 268,677 |
Total liabilities and stockholders’ equity | $ 256,322 | $ 287,401 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in usd per share) | $ 0.005 | $ 0.005 |
Preferred stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in usd per share) | $ 0.005 | $ 0.005 |
Common stock, authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, issued (in shares) | 59,190,000 | 58,010,000 |
Common stock, outstanding (in shares) | 59,190,000 | 58,010,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | ||
Revenue | $ 135,190 | $ 114,342 |
Cost of revenue | 34,163 | 31,098 |
Gross profit | 101,027 | 83,244 |
Operating expenses: | ||
Research and development | 59,258 | 34,414 |
Sales and marketing | 72,839 | 47,045 |
General and administrative | 40,738 | 25,614 |
Total operating expenses | 172,835 | 107,073 |
Loss from operations | (71,808) | (23,829) |
Other income (expense) | ||
Interest and other income | 1,702 | 106 |
Interest and other expense | (473) | (540) |
Loss from operations before income taxes | (70,579) | (24,263) |
Income tax provision | (186) | (81) |
Net loss | (70,765) | (24,344) |
Less accretion of redeemable convertible preferred stock | 0 | (56) |
Net loss attributable to common stockholders | (70,765) | (24,400) |
Net loss attributable to common stockholders | $ (70,765) | $ (24,400) |
Net loss attributable to common shareholders, basic (in dollars per share) | $ (1.20) | $ (0.73) |
Net loss attributable to common shareholders, diluted (in dollars per share) | $ (1.20) | $ (0.73) |
Weighted-average shares used in computing net loss per share attributable to common shareholders, basic (in shares) | 58,753 | 33,208 |
Weighted-average shares used in computing net loss per share attributable to common shareholders, diluted (in shares) | 58,753 | 33,208 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands | Total | Common stock | Additional paid-in capital | Accumulated deficit |
Redeemable convertible preferred stock at beginning of period (in shares) at Dec. 31, 2020 | 35,793 | |||
Redeemable convertible preferred stock balance at beginning of period at Dec. 31, 2020 | $ 160,800 | |||
Increase (Decrease) in Temporary Equity [Roll Forward] | ||||
Accretion to redemption value | $ 56 | |||
Conversion of redeemable convertible preferred stock (in shares) | (35,793) | |||
Conversion of redeemable convertible preferred stock | $ (160,856) | |||
Redeemable convertible preferred stock at end of period (in shares) at Dec. 31, 2021 | 0 | |||
Redeemable convertible preferred stock balance at end of period at Dec. 31, 2021 | $ 0 | |||
Stockholders' equity at beginning of period (in shares) at Dec. 31, 2020 | 13,533 | |||
Stockholder's equity at beginning of period at Dec. 31, 2020 | (94,923) | $ 68 | $ 8,129 | $ (103,120) |
Stockholders' Equity | ||||
Accretion to redemption value | (56) | (56) | ||
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs (in shares) | 7,500 | |||
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs | 219,527 | $ 37 | 219,490 | |
Conversion of redeemable convertible preferred stock (in shares) | 35,793 | |||
Conversion of redeemable convertible preferred stock | $ 160,856 | $ 179 | 160,677 | |
Exercise of stock options (in shares) | 1,033 | 933 | ||
Exercise of stock options | $ 2,287 | $ 6 | 2,281 | |
Exercise of warrants (in shares) | 50 | |||
Exercise of warrants | 146 | 146 | ||
Issuance of RSAs (in shares) | 201 | |||
Issuance of RSAs | 0 | $ 1 | (1) | |
Repurchase of common stock related to net share settlement (in shares) | (15) | |||
Repurchase of common stock related to net share settlement | (476) | (476) | ||
Vesting of restricted stock units (in shares) | 15 | |||
Stock compensation expense | 5,660 | 5,660 | ||
Net loss | $ (24,344) | (24,344) | ||
Stockholders' equity at end of period (in shares) at Dec. 31, 2021 | 58,010 | 58,010 | ||
Stockholder's equity at end of period at Dec. 31, 2021 | $ 268,677 | $ 291 | 395,850 | (127,464) |
Increase (Decrease) in Temporary Equity [Roll Forward] | ||||
Accretion to redemption value | $ 0 | |||
Stockholders' Equity | ||||
Exercise of stock options (in shares) | 922 | 922 | ||
Exercise of stock options | $ 4,059 | $ 4 | 4,055 | |
Repurchase of common stock related to net share settlement (in shares) | (7) | |||
Repurchase of common stock related to net share settlement | (264) | (264) | ||
Vesting of restricted stock units (in shares) | 265 | |||
Vesting of restricted stock units | 0 | $ 1 | (1) | |
Stock compensation expense | 21,929 | 21,929 | ||
Net loss | $ (70,765) | (70,765) | ||
Stockholders' equity at end of period (in shares) at Dec. 31, 2022 | 59,190 | 59,190 | ||
Stockholder's equity at end of period at Dec. 31, 2022 | $ 223,636 | $ 296 | $ 421,569 | $ (198,229) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flow from operating activities: | ||
Net loss | $ (70,765) | $ (24,344) |
Adjustments to reconcile net loss to cash used in operations: | ||
Depreciation and amortization | 2,974 | 1,674 |
Stock-based compensation | 21,737 | 5,603 |
Charge to allowance for credit losses | 1,294 | 833 |
Loss (gain) on disposal of long-lived assets | (1) | (1) |
Unoccupied lease charges | 1,127 | 0 |
Remeasurement of contingent consideration | 540 | 0 |
Non-cash operating lease costs | 1,452 | 986 |
Non-cash interest | 0 | 240 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (3,274) | (8,662) |
Other current assets | (989) | (3,168) |
Other long-term assets | (237) | (24) |
Accounts payable | 3,186 | 1,091 |
Accrued expenses and other | (4,199) | 4,615 |
Deferred revenue | 1,621 | 533 |
Operating lease liabilities | (614) | (1,018) |
Other liabilities | 134 | 0 |
Net cash used in operating activities | (46,014) | (21,642) |
Cash flow from investing activities: | ||
Purchases of property, equipment and capitalized internal-use software development costs | (4,378) | (3,107) |
Cash paid for acquisitions | (5,310) | 0 |
Net cash used in investing activities | (9,688) | (3,107) |
Cash flow from financing activities: | ||
Proceeds from public offering, net of underwriting discounts and commissions and other offering costs | (284) | 219,811 |
Proceeds from exercise of stock options | 4,059 | 2,288 |
Proceeds from exercise of warrants | 0 | 146 |
Repurchase of common stock related to net share settlement | (264) | (476) |
Principal payments on finance lease obligations | (42) | (112) |
Net cash provided by financing activities | 3,469 | 221,657 |
Net increase (decrease) in cash and cash equivalents: | (52,233) | 196,908 |
Cash and cash equivalents at beginning of period | 255,477 | 58,569 |
Cash and cash equivalents at end of period | 203,244 | 255,477 |
Supplemental disclosure: | ||
Cash paid for interest | 0 | 105 |
Cash paid for taxes | 397 | 97 |
Non-cash investing and financing activities: | ||
Accretion of preferred stock to redemption value | 0 | 56 |
Property and equipment included in accounts payable and accrued liabilities | 240 | 0 |
Conversion of preferred stock to common stock upon initial public offering | 0 | 160,856 |
Costs related to initial public offering included in accounts payable | 0 | 284 |
Acquisition holdback | 800 | 0 |
Contingent consideration related to acquisition | $ 1,133 | $ 0 |
Organization and Nature of Oper
Organization and Nature of Operations | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Nature of Operations | Organization and Nature of Operations CS Disco, Inc. (the “Company” or “DISCO”) has built a cloud-native, AI-powered software platform that enterprises, law firms, legal services providers, and governments use for legal hold, legal request, ediscovery, legal document review and case management in a wide variety of legal matters, ranging from litigation to investigations to compliance to diligence. The Company incorporated as a Delaware corporation on December 2, 2013. The Company’s headquarters are located in Austin, Texas. Public Offerings On July 23, 2021, the Company completed the initial public offering (“IPO”) of its common stock pursuant to a Registration Statement on Form S-1. In the IPO, the Company sold an aggregate of 7,500,000 shares of common stock, including 500,000 shares issued pursuant to the underwriters’ option to purchase additional shares at a public offering price of $32.00 per share. The IPO resulted in net proceeds of approximately $223.2 million, after deducting underwriting discounts and commissions of $16.8 million. An existing stockholder sold an additional 200,000 shares of common stock pursuant the underwriters’ option to purchase additional shares of common stock at $32.00 per share. The Company did not receive any proceeds from the sale of shares by the selling stockholder in the IPO. Offering expenses incurred by the Company for the IPO were approximately $3.7 million and were recorded against stockholders’ equity. Upon the completion of the IPO, all outstanding shares of the Company’s redeemable convertible preferred stock were converted into 35,793,483 shares of common stock. On September 17, 2021, the Company completed a secondary public offering of its common stock pursuant to a Registration Statement on Form S-1. In the secondary offering, selling stockholders sold an aggregate of 6,050,000 shares of common stock, including 550,000 shares sold pursuant to the underwriters’ option to purchase additional shares at an offering price of $53.00 per share. The Company did not receive any proceeds from the sale of shares through the secondary offering. Offering expenses incurred by the Company that were not subject to reimbursement were approximately $0.1 million and were recorded as general and administrative expense. The total number of outstanding shares of common stock remained unchanged as a result of the secondary offering. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards, which allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. The Company has irrevocably opted not to use the extended transition period for complying with any new or revised financial accounting standards, and as such, the Company is required to adopt new or revised standards at the same time as other public companies. An emerging growth company may also take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including reduced reporting requirements and other exemptions. Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in accordance with U. S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company. All significant intercompany balances and transactions have been eliminated. There are no differences between the net loss and comprehensive loss. Risks and Uncertainties Fluctuations in general macroeconomic conditions, such as the current inflationary environment and rising interest rates, the COVID-19 pandemic and Russian military operations in Ukraine, have not had a material impact on the Company’s operations, but could do so in the future. The Company assessed the impact these events had on its results of operations, including, but not limited to an assessment of its allowance for credit losses, the carrying value of other long-lived assets, including goodwill and intangibles, and the impact to revenue recognition and cost of revenue. While these events have not had a material adverse impact on the Company’s financial operations to date, the future impacts are largely unknown. The Company will continue to actively monitor the impact that these events have on the results of the Company’s business operations, and may make decisions required by federal, state or local authorities, or that are determined to be in the best interests of the Company’s employees, customers, partners, suppliers and stockholders. As a result, the Company’s estimates and judgments may change materially as new events occur or additional information becomes available to them. Use of Estimates The preparation of these consolidated financial statements in conformity with GAAP requires the Company to make certain estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses during the reporting period. There is complexity and judgment required in the Company’s process in determining the nature and timing of the satisfaction of performance obligations which affect the amounts of revenue, unbilled receivables and deferred revenue. Estimates are also used for, but not limited to, current expected credit losses, capitalization and useful life of the Company’s capitalized internal-use software development costs, useful lives of assets, fair value of acquired intangible assets, carrying value of goodwill, fair value of contingent consideration, income taxes and deferred tax asset valuation and valuation of the Company’s stock-based awards. Numerous internal and external factors can affect estimates. Actual results could differ from those estimates and such differences could be material to the Company’s consolidated financial position and results of operations. Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Under the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of stock options, restricted stock awards, restricted stock units, and performance-based restricted stock units. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share. Cash and Cash Equivalents The Company considers all highly liquid investments acquired with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents, which include the Company’s money market account, are measured at fair value on a recurring basis. Accounts Receivable Accounts receivable are recorded and carried at the original invoiced amount less an allowance for credit losses. The Company determines its trade accounts receivable allowances in line with (Topic 326): Measurement of Credit Losses on Financial Instruments (“Topic 326”), based upon the assessment of various factors, such as: historical experience, credit quality of its customers, geographic related risks, economic conditions and other factors that may affect a customer’s ability to pay. Increases and decreases in the allowance for credit losses are included as a component of general and administrative expense in the consolidated statements of operations and comprehensive loss. The Company does not have any off-balance sheet credit exposure related to its customers. The Company has provisioned $1.4 million for expected losses for the year ended December 31, 2022, and $1.0 million has been written off and charged against the allowance for the year ended December 31, 2022. Recoveries made by the Company were $0.1 million for the year ended December 31, 2022. The allowance for credit losses related to accounts receivable was $1.5 million and $1.2 million as of December 31, 2022 and December 31, 2021, respectively. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and trade accounts receivable. The Company maintains its cash and cash equivalent balances in highly rated financial institutions, which at times may exceed federally insured limits or be held in foreign jurisdictions. The Company has not experienced any loss relating to cash and cash equivalents in these accounts. The Company performs periodic credit evaluations of its customers’ financial condition and generally does not require collateral. Fair Value of Financial Instruments The Company groups its assets and liabilities measured at fair value in a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets, with valuations obtained from readily available pricing sources for market transactions involving identical assets or liabilities; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level of the fair value hierarchy in which the fair value measurement falls is determined by the lowest level input that is significant to the fair value measurement. The Company’s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are considered to approximate their respective fair values due to the short-term nature of such financial instruments. Cash equivalents, primarily consisting of investments in money market funds, are measured at fair value on a recurring basis, and are categorized as Level 1 based on quoted prices in active markets. The carrying value approximates the fair value for these assets and liabilities at December 31, 2022 and 2021. The Company recognizes transfers between levels at the end of the reporting period as if the transfers occurred on the last day of the reporting period. There were no transfers during the years ended December 31, 2022 and 2021. Property and Equipment, Net Property and equipment are recorded at cost, less accumulated depreciation. Maintenance, repairs and minor replacements are charged to expense as incurred. Significant renewals and betterments are capitalized. Depreciation on property and equipment, with the exception of leasehold improvements, is recorded using the straight-line method over the estimated useful lives of the assets. Depreciation on leasehold improvements is recorded using the shorter of the lease term or useful life. The estimated useful life of each asset category is as follows: Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or 5 years Computer equipment 2 years The Company periodically reviews the estimated useful lives of property and equipment and any changes to the estimated useful lives are recorded prospectively from the date of the change. When property is retired or disposed of, the cost and related accumulated depreciation are removed from the accounts and any resulting gains or losses are reflected in the consolidated statements of operations and comprehensive loss in the period of disposal. Capitalized Internal-Use Software Development Costs Costs related to software acquired, developed, or modified solely to meet the Company’s internal requirements, with no plans to market such software at the time of development, are capitalized. Costs incurred during the preliminary planning and evaluation stage of the project and during the post implementation operational stage are expensed as incurred. The Company capitalizes qualifying internal-use software development costs that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Costs incurred for maintenance, minor upgrades and enhancements are expensed. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred. Capitalized costs are included in property and equipment, net on the consolidated balance sheets. These costs are amortized over the estimated useful life of the software, generally four years, on a straight-line basis. Management evaluates the useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The amortization of costs related to the platform applications is included in cost of revenue. Purchase Price Allocation, Intangible Assets and Goodwill The purchase price allocation for business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values. The Company determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this threshold is met, the single asset or group of assets, as applicable, is not a business. If it is not met, the Company determines whether the single asset or group of assets, as applicable, meets the definition of a business. In connection with the Company’s acquisition of legal workflow solutions from Congruity360, LLC (“Congruity”) discussed in Note 9, “Acquisitions, Intangible Assets and Goodwill,” the Company recorded certain intangible assets, including developed technology and customer relationships. Amounts allocated to the acquired intangible assets are being amortized on a straight-line basis over the estimated useful lives. The Company periodically reviews the estimated useful lives and fair values of its identifiable intangible assets, taking into consideration any events or circumstances which might result in a diminished fair value or revised useful life. The excess purchase price over the fair value of assets acquired is recorded as goodwill. The Company tests goodwill for impairment annually during the fourth quarter, or whenever events or changes in circumstances indicate an impairment may have occurred. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, in which case an impairment charge is recorded to goodwill to the extent the carrying value exceeds the fair value, limited to the amount of goodwill. The Company did not recognize any impairment of goodwill for all periods presented. Debt Issuance Costs The Company records underwriting, legal and other direct costs incurred related to the issuance of the revolving line of credit within other current assets and amortizes these costs to interest expense over the term of the related debt on a straight-line basis, which approximates the effective interest rate method. Upon the extinguishment of the related debt in November 2021, $0.2 million of unamortized capitalized deferred financing costs were recorded to interest expense. There was no amortization expense related to debt issuance costs for the year ended December 31, 2022. Leases The Company determines if an arrangement is or contains a lease at contract inception. The Company presents the operating leases in long-term assets and current and long-term liabilities in the consolidated balance sheets. Finance lease assets are included in property and equipment, net, and finance lease liabilities are presented in current and long-term liabilities on the consolidated balance sheets. Right-of-use assets represent the Company’s right to use an underlying asset over the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company includes any anticipated lease incentives in the determination of lease liabilities. The Company uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments. The Company gives consideration to its recent debt issuances as well as publicly available data for instruments with similar characteristics when determining its incremental borrowing rates. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever an event or change in circumstances indicates that the carrying amount of an asset or group of assets may not be recoverable. The impairment review includes comparison of future cash flows expected to be generated by the asset or group of assets with the associated assets’ carrying value. If the carrying value of the asset or group of assets exceeds its expected future cash flows (undiscounted and without interest charges), an impairment loss is recognized to the extent that the carrying amount of the asset exceeds its fair value. The Company did not identify any impairment indicators and recorded no impairment charges in the years ended December 31, 2022 or 2021. Segment Information The Company’s Chief Executive Officer is the chief operating decision maker, who reviews the Company’s financial information presented on a consolidated basis for purposes of allocating resources and evaluating the Company’s financial performance. Accordingly, the Company has determined that it operates in a single reporting segment. Revenue Recognition Refer to Note 3, “Revenue” for the Company’s Revenue Recognition policy. Advertising The Company expenses advertising costs as incurred. Advertising expenses were $3.1 million and $0.4 million for the years ended December 31, 2022 and 2021, respectively. These costs are included in sales and marketing expenses in the consolidated statements of operations and comprehensive loss. Cost of Revenue Cost of revenue consists primarily of third-party cloud infrastructure expenses incurred in connection with the Company’s customers’ use of its solutions. Cost of revenue also includes outsourced staffing costs, amortization of internal-use software and personnel costs from employees involved in the delivery of the Company’s solutions. Personnel costs include salaries, benefits, bonuses, stock-based compensation and allocated overhead costs. Research and Development Research and development expenses consist primarily of personnel-related costs for the Company’s development team, including salaries, benefits, bonuses, stock-based compensation expenses and allocated overhead costs. Research and development expenses also include contractor or professional services fees, third-party cloud infrastructure expenses incurred in developing the Company’s solution and software services dedicated for use by the Company’s research and development organization. Sales and Marketing Sales and marketing expenses consist primarily of personnel-related costs directly associated with the Company’s sales and marketing staff, including salaries, benefits, bonuses, commissions, stock-based compensation and allocated overhead costs. Sales and marketing expenses also include advertising costs and other expenses associated with the Company’s marketing and business development programs. In addition, sales and marketing expenses are comprised of travel-related expenses, software services dedicated for use by the Company’s sales and marketing organizations and outside services contracted for sales and marketing purposes. General and Administrative General and administrative expenses consist of personnel-related costs associated with the Company’s finance, legal, human resources and administrative personnel, including salaries, benefits, bonuses, stock-based compensation and allocated overhead costs. General and administrative expenses also include external legal, accounting, professional services fees, software services dedicated for use by the Company’s general and administrative functions, insurance, allowance for credit losses and other corporate expenses. Stock-Based Compensation The Company measures and recognizes compensation expense for all stock-based awards (collectively referred to as stock-based compensation expense), including stock options, restricted stock awards, restricted stock units and performance-based restricted stock units granted to employees, directors and non-employees, based on the estimated fair value of the awards on the date of grant in accordance with ASC Topic 718 Compensation - Stock Compensation (“Topic 718”). The fair value of each stock option granted prior to the IPO was estimated using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the Company to make assumptions and judgments about the inputs used in the calculation, including the expected term, the volatility of the Company’s common stock, risk-free interest rate and expected dividend yield. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The fair value of stock options granted after the IPO, restricted stock awards, restricted stock units and performance-based restricted stock units is determined using the fair value of the Company’s common stock on the date of grant. Forfeitures are accounted for in the period in which they occur. Stock-based compensation is recognized following the straight-line attribution method over the requisite service period for stock options, restricted stock awards and restricted stock units. Stock-based compensation is recognized under the accelerated attribution method over the requisite service period for performance-based restricted stock units. Sales Taxes The Company recognizes sales and other taxes collected from customers and subsequently remits the taxes to government authorities. The Company relieves the sales tax payable balances from the consolidated balance sheets as cash is collected from the customer and the taxes are remitted to the appropriate tax authority. Contingent Consideration On February 22, 2022, the Company acquired legal workflow solutions from Congruity. As part of the acquisition, the Company entered into a referral agreement in which the Company could be obligated to pay Congruity an additional $2.0 million in the aggregate over a remaining period of 1.96 years. As of December 31, 2022, the estimated fair value of the contingent consideration utilizing a probability weighted scenario analysis model under the scenario-based method was $1.1 million. The short-term and long-term portions of this amount are recorded in accounts payable and other liabilities, respectively, on the consolidated balance sheet. The fair value of the contingent consideration was determined using Level 3 inputs due to estimates for the number and size of referrals, the likelihood of shortfall and any credits that will offset the liability. These estimated inputs reflect management’s best estimate of future results, but these estimates are not observable inputs by a market participant and contain a high degree of uncertainty. The Company could experience significant fluctuations in the fair value of contingent consideration based on actual results. The fair value of this contingent consideration will continue to be revalued on a quarterly basis. Changes in the fair value of the contingent consideration are recorded as operating expense in the consolidated statements of operations and comprehensive loss. As of December 31, 2022, none of the contingent consideration was paid. Income Taxes The Company accounts for income taxes in accordance with the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that are expected to apply to taxable income in the periods in which the deferred tax asset or liability is expected to be realized or settled. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized. All deferred tax assets and liabilities are classified as non-current within the accompanying consolidated balance sheets. The Company recognizes the tax benefit from an uncertain tax position only if it meets the “more likely than not” threshold that the position will be sustained upon examination by the taxing authority, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. The Company includes interest and penalties related to its uncertain tax positions, if any, as part of income tax expense within the accompanying consolidated statements of operations and comprehensive loss. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties as of December 31, 2022 and 2021. Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, “ Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ” which intends to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. The Company adopted this guidance as of January 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. |
Revenue Recognition
Revenue Recognition | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition Revenue is recognized, in an amount that reflects the consideration the Company expects to be entitled to over the term of the agreement, when control of the Company’s solutions are transferred to customers. The Company recognizes revenue through the following five-step framework in accordance with ASC Topic 606, Revenue from Contracts with Customers : (1) Identification of the contract, or contracts, with the customer; (2) Identification of performance obligations in the contract; (3) Determination of the transaction price; (4) Allocation of the transaction price to the performance obligations in the contract; (5) Recognition of revenue when, or as, the Company satisfies a performance obligation. A performance obligation is a promise in a contract to transfer a distinct solution to the customer. The Company identifies performance obligations in its contracts with customers, which primarily include usage-based and subscription solutions. Usage-based solutions include fees based on usage of the Company’s platform or professional services, incurred on a time and materials basis, while subscription solutions represent the purchase of a committed data volume on the Company’s platform over a period of time. The transaction price is determined based on the amount which the Company expects to be entitled to in exchange for providing the promised services to the customer. For contracts that include multiple performance obligations, the transaction price in the contract is allocated to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized over time as performance obligations are satisfied. Variable consideration is evaluated on a contract-by-contract basis, and a constraint is applied using the facts and circumstances of the contract when applicable. On a limited basis, the Company enters into contracts whereby the consideration payable is contingent upon the conclusion of the legal matter. The Company does not recognize the revenue related to these contracts until the legal matter is resolved. Such amounts recognized have been immaterial to date. The Company’s software contracts do not allow the customer to take possession of the software supporting the cloud-based solution. Customers are not entitled to any refunds. The Company’s arrangements do not contain general rights of return. However, credits may be issued on a case-by-case basis. Amounts that have been invoiced are recorded in accounts receivable and in revenue or deferred revenue depending on whether the revenue recognition criteria have been met. Nature of Solutions The Company’s revenue-generating activities directly relate to the sale and support of its legal solution within a single operating segment. The Company disaggregates revenue from contracts with customers based on how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company has two primary types of contractual arrangements: usage-based and subscription solutions. Usage-based revenue is generated from solutions that are typically billed on a monthly basis and can be canceled with one month’s notice or are incurred on a time and materials basis. Subscription revenue is derived from contracts where customers are contractually committed to a fixed data volume over a period of time. Usage amounts above the fixed data volume are considered usage-based revenue. Subscription arrangements are billed in advance, typically on a monthly, quarterly or annual basis. Subscription revenue is recognized ratably over the life of the contract. In the years ended December 31, 2022 and 2021, usage-based revenue represented 89% of total revenue. In the years ended December 31, 2022 and 2021, subscription revenue fees represented 11% of total revenue. No significant judgments are required in determining whether services are considered distinct performance obligations and should be accounted for separately versus together, or to determine the stand-alone selling price (“SSP”). Deferred Revenue Deferred revenue primarily consists of amounts that have been billed to or received from customers in advance of performing the associated services. Of the $2.2 million and $1.6 million of deferred revenue balance as of December 31, 2021 and 2020, respectively, the Company recognized $2.2 million and $1.6 million as revenue during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022 and 2021 the Company recorded $4.1 million and $2.2 million of current deferred revenue, respectively. The Company’s non-current deferred revenue was nominal as of December 31, 2022. No non-current deferred revenue was recorded as of December 31, 2021. Contract Assets Contract assets represent revenue recognized for contracts that have not yet been invoiced to customers, but are billed in arrears and for which the Company has an unconditional right to payment. Total contract assets were $2.0 million and $3.2 million as of December 31, 2022 and December 31, 2021, respectively, and were included within accounts receivable on the consolidated balance sheets. Remaining Performance Obligations Remaining performance obligations (“RPO”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. RPO exclude performance obligations from certain time and materials contracts that are billed in arrears. RPO are not necessarily indicative of future revenue growth because they do not account for consumption in excess of contracted capacity. As of December 31, 2022, the Company expects to recognize approximately $21.5 million of revenue from remaining performance obligations. The Company expects to recognize revenue of approximately $13.4 million as of December 31, 2022 from remaining performance obligations over the next 12 months, with the remaining balance recognized thereafter. Incremental Contract Costs Incremental costs to obtain or fulfill a contract are recognized as an asset if the expected benefit is expected to be longer than one year. These assets are amortized over the expected period of benefit. For the years ended December 31, 2022 and 2021, the Company identified no material incremental costs to obtain or fulfill a contract, primarily based on the nature and terms of the Company’s contracts, as well as the expected period of benefit. |
Property and Equipment
Property and Equipment | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and Equipment Property and equipment consist of the following (in thousands): December 31, December 31, Computer equipment $ 5,089 $ 3,079 Capitalized internal-use software 6,707 5,168 Leasehold improvements 467 111 Furniture 1,185 649 Total property and equipment 13,448 9,007 Less: accumulated depreciation and amortization (5,941) (3,672) Property and equipment, net $ 7,507 $ 5,335 Depreciation and amortization expense relating to the Company’s property and equipment was $2.7 million and $1.6 million for the years ended December 31, 2022 and 2021 , respectively. Amortization expense relating to the cost of revenue for capitalized internal-use software was $1.2 million and $0.7 million for the years ended December 31, 2022 and 2021 respectively. The Company capitalized $1.5 million and $1.9 million in internal-use software development costs in the years ended December 31, 2022 and 2021 , respectively. As of December 31, 2022 and 2021 the unamortized balance of capitalized internal-use software costs on the Company’s consolidated balance sheets was approximately $4.3 million and $4.0 million, respectively. No impairment indicators were identified when the capitalized development costs were assessed for impairment for the years ended December 31, 2022 and 2021 . |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases As of December 31, 2022, the Company leases office spaces under non-cancellable operating leases for its corporate headquarters in Austin, Texas and its office space in New York, New York. Pursuant to the corporate headquarters lease in Austin, the initial term expires on July 31, 2028, and pursuant to the lease in New York, the initial term expires on May 15, 2023, with an option to extend the lease for an additional six months. The optional period for the New York lease has been included in the lease term in the determination of the operating lease right-of-use assets or operating lease liabilities associated with the lease as the Company considers it reasonably certain it will exercise the option. As of December 31, 2022, the Company had one leased property classified as a “short-term” lease in London, United Kingdom. In accordance with Topic 842, leases with a term of 12 months or less are not recorded on the Company’s consolidated balance sheet. For operating leases other than the short-term lease, the Company recognizes a right-of-use-asset and lease liability in accordance with Topic 842. The asset and liability are then amortized as payments are made. The Company incurred $1.1 million in unoccupied lease expense for leased facilities in Austin, Texas for the related contractual lease payments and fees for the year ended December 31, 2022. The Company did not incur any unoccupied lease expense during the year ended December 31, 2021. The cost of leases recorded in the accompanying consolidated statements of operations and comprehensive loss were as follows (in thousands): Year Ended Operating lease expense $ 1,784 Finance lease expense Amortization expense 56 Interest on lease liability 7 Short-term lease expense Lease expense 227 Total lease cost $ 2,074 The Company’s operating and finance right-of-use assets and lease liabilities are as follows (in thousands): Leases Classification December 31, 2022 Assets Operating lease assets Operating right-of-use asset, net of accumulated amortization $ 9,824 Finance lease assets Property and equipment, net of accumulated depreciation 217 Total leased assets $ 10,041 Liabilities Current Operating leases Operating lease liability, current $ 1,902 Finance leases Finance lease liability, current 39 Non-current Operating leases Operating lease liability, non-current 8,770 Finance leases Finance lease liability, non-current 199 Total lease liabilities $ 10,910 Supplemental cash flow information related to leases as of December 31, 2022 was as follows (in thousands) : Cash paid for operating lease liabilities $ 782 Cash paid for financing lease liabilities $ 42 Right-of-use assets obtained in exchange for operating lease liabilities $ 10,935 The weighted average remaining lease term and discount rate as of December 31, 2022 are as follows: Weighted Average Remaining Lease Term Operating leases 5.43 years Finance leases 5.59 years Weighted Average Discount Rate Operating leases 5.00 % Finance leases 5.00 % Future minimum payments required under operating leases, by year and in aggregate, that have initial or remaining non-cancellable lease terms in excess of one year, are as follows (in thousands): Year Ended Operating Finance 2023 $ 2,391 $ 47 2024 2,036 47 2025 2,098 47 2026 2,162 47 2027 2,229 47 Thereafter 1,333 28 Total $ 12,249 $ 263 As of December 31, 2022, the Company had no additional operating or finance leases with future commencement dates. |
Leases | Leases As of December 31, 2022, the Company leases office spaces under non-cancellable operating leases for its corporate headquarters in Austin, Texas and its office space in New York, New York. Pursuant to the corporate headquarters lease in Austin, the initial term expires on July 31, 2028, and pursuant to the lease in New York, the initial term expires on May 15, 2023, with an option to extend the lease for an additional six months. The optional period for the New York lease has been included in the lease term in the determination of the operating lease right-of-use assets or operating lease liabilities associated with the lease as the Company considers it reasonably certain it will exercise the option. As of December 31, 2022, the Company had one leased property classified as a “short-term” lease in London, United Kingdom. In accordance with Topic 842, leases with a term of 12 months or less are not recorded on the Company’s consolidated balance sheet. For operating leases other than the short-term lease, the Company recognizes a right-of-use-asset and lease liability in accordance with Topic 842. The asset and liability are then amortized as payments are made. The Company incurred $1.1 million in unoccupied lease expense for leased facilities in Austin, Texas for the related contractual lease payments and fees for the year ended December 31, 2022. The Company did not incur any unoccupied lease expense during the year ended December 31, 2021. The cost of leases recorded in the accompanying consolidated statements of operations and comprehensive loss were as follows (in thousands): Year Ended Operating lease expense $ 1,784 Finance lease expense Amortization expense 56 Interest on lease liability 7 Short-term lease expense Lease expense 227 Total lease cost $ 2,074 The Company’s operating and finance right-of-use assets and lease liabilities are as follows (in thousands): Leases Classification December 31, 2022 Assets Operating lease assets Operating right-of-use asset, net of accumulated amortization $ 9,824 Finance lease assets Property and equipment, net of accumulated depreciation 217 Total leased assets $ 10,041 Liabilities Current Operating leases Operating lease liability, current $ 1,902 Finance leases Finance lease liability, current 39 Non-current Operating leases Operating lease liability, non-current 8,770 Finance leases Finance lease liability, non-current 199 Total lease liabilities $ 10,910 Supplemental cash flow information related to leases as of December 31, 2022 was as follows (in thousands) : Cash paid for operating lease liabilities $ 782 Cash paid for financing lease liabilities $ 42 Right-of-use assets obtained in exchange for operating lease liabilities $ 10,935 The weighted average remaining lease term and discount rate as of December 31, 2022 are as follows: Weighted Average Remaining Lease Term Operating leases 5.43 years Finance leases 5.59 years Weighted Average Discount Rate Operating leases 5.00 % Finance leases 5.00 % Future minimum payments required under operating leases, by year and in aggregate, that have initial or remaining non-cancellable lease terms in excess of one year, are as follows (in thousands): Year Ended Operating Finance 2023 $ 2,391 $ 47 2024 2,036 47 2025 2,098 47 2026 2,162 47 2027 2,229 47 Thereafter 1,333 28 Total $ 12,249 $ 263 As of December 31, 2022, the Company had no additional operating or finance leases with future commencement dates. |
Operating Segment and Geographi
Operating Segment and Geographic Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Operating Segment and Geographic Information | Operating Segment and Geographic Information The Company’s Chief Executive Officer is the chief operating decision maker, who reviews the Company’s financial information presented on a consolidated basis for purposes of allocating resources and evaluating the Company’s financial performance. Accordingly, the Company has determined that it operates in a single reporting segment. The Company determines the location of revenue using the billing address of each customer. The following table sets forth revenue by geographic area (in thousands): Year Ended 2022 2021 United States $ 126,504 $ 107,084 All other countries 8,686 7,258 Total revenue $ 135,190 $ 114,342 Long-lived assets outside of the United States are not significant. |
Debt and Related Warrants
Debt and Related Warrants | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt and Related Warrants | Debt and Related Warrants In July 2015, the Company entered into a revolving debt facility (“Loan and Security Agreement”). The Loan and Security Agreement was subsequently amended and restated, the First Amended and Restated Loan and Security Agreement, in November 2018 to increase the available borrowings to $18.0 million and extend the maturity date to April 2021. In December 2020, the Company entered into the Second Amended and Restated Loan and Security Agreement, which provided a $40.0 million revolving credit facility with a maturity date of November 30, 2023. The Company’s obligations under the agreement contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures and affiliate transactions. The agreement also contained a liquidity covenant equal to the greater of (i) $5.0 million or (ii) total six-month adjusted EBITDA burn when the sum of the outstanding principal amounts are equal or in excess of $18.0 million. The revolving credit facility bore interest on outstanding borrowings as the sum of the Daily Adjusting LIBOR Rate for such day plus 2.50% plus an applicable margin of 0.25% per annum. Additionally, the revolving debt facility included an unused facility fee equal to 0.25% per annum of the difference between the total revolving credit facility and the average outstanding principal balance of the obligations under the revolving credit facility during each quarter. Substantially all the Company’s assets were pledged as collateral for these loans. The Company was required to meet certain nonfinancial covenants. In connection with its amended and restated loan and security agreements, at various times, the Company granted warrants to purchase 49,869 shares of the Company’s common stock at exercise prices ranging from $0.525 per share to $10.80 per share. The warrants are exercisable for 10 years. At the time of issuance, the Company determined the estimated fair value of the warrants. As the warrants represent a freestanding equity instrument, the Company recorded the fair value of the warrants in additional paid in capital. In October 2021, all outstanding warrants were exercised for a total of $0.1 million. In November 2021, the Company extinguished the Loan and Security Agreement. The Company did not incur any early termination fees in connection with the termination of the agreement. The Company had no outstanding debt as of December 31, 2022. The Company incurred nominal aggregate debt issuance costs in connection with its loan and security agreements. These costs were being amortized to non-cash interest expense over the terms of the related indebtedness using the straight-line method which approximates the effective interest method. In connection with the extinguishment of the Loan and Security Agreement in November 2021, the Company recognized the remaining $0.2 million of debt issuance costs as interest expense. There was no amortization expense related to debt issuance costs for the year ended December 31, 2022. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Leases and Other Commitments The Company leases office facilities under non-cancellable operating leases as well as furniture under a non-cancellable finance lease. See Note 5, “Leases,” for additional detail on the Company’s operating and finance lease commitments arising from these agreements. Additionally, the Company has contractual commitments that are noncancellable and expire within one Purchase obligations December 31, 2022 2023 $ 18,966 2024 18,434 2025 18,135 Thereafter — Total $ 55,535 Litigation From time to time, the Company is involved in various legal proceedings arising from the normal course of business activities. The Company accrues liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company currently does not believe that the ultimate outcome of any matters is probable or reasonably estimable, or that these matters will have a material adverse effect on the Company’s business, operating results, cash flows or financial condition; however, the results of litigation and claims are inherently unpredictable. Regardless, of the outcome, litigation can have an adverse impact on the Company because of litigation and settlement costs, diversion of management resources, and other factors. |
Acquisitions, Intangible Assets
Acquisitions, Intangible Assets and Goodwill | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions, Intangible Assets and Goodwill | Acquisitions, Intangible Assets and Goodwill Congruity Acquisition On February 22, 2022, the Company entered into an asset purchase agreement whereby the Company acquired legal workflow solutions from Congruity in exchange for approximately $6.1 million of cash, including a holdback of $0.8 million to be paid in fiscal year 2023, and up to $2.0 million of contingent consideration. As of December 31, 2022, the estimated fair value of the contingent consideration was $1.1 million. The Company incurred $0.5 million of expense related to the revaluation of the of the contingent consideration for the year ended December 31, 2022. The legal workflow solutions expanded the Company’s offerings to provide a modern, digital solution for legal hold obligations and legal request compliance. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations . The resulting goodwill will be deductible for income tax purposes. Pro forma results of operations for this acquisition have not been presented because the acquisition was not material to the consolidated results of operations and comprehensive loss. Transaction costs amounted to approximately $0.1 million and were expensed as incurred. The aggregate purchase consideration and estimated fair values of the assets acquired and liabilities assumed at the date of acquisition were as follows (in thousands): Fair Value Fair value of net assets acquired: Net tangible assets (liabilities) $ (395) Developed technology 900 Customer relationships 300 Goodwill 5,898 Total fair value of net assets acquired $ 6,703 Intangible Assets Intangible assets, net consisted of the following (in thousands): December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Developed technology $ 900 $ (153) $ 747 5 years Customer relationships 300 (85) 215 3 years Total $ 1,200 $ (238) $ 962 Intangible amortization expense was $0.2 million for the year ended December 31, 2022. Amortization expense related to developed technology and customer relationships is included in cost of revenue and operating expenses, respectively, on the consolidated statements of operations and comprehensive loss. As of December 31, 2022, future amortization expense by year is expected to be as follows (in thousands): Amount 2023 $ 280 2024 280 2025 195 2026 180 2027 27 Total $ 962 Goodwill The changes in the carrying amount of goodwill during the year ended December 31, 2022 were as follows (in thousands): Amount Balance as of December 31, 2021 $ — 2022 acquisition 5,898 Total $ 5,898 |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation Equity Incentive Plans On December 17, 2013, the Company adopted the Long-Term Incentive Plan (“2013 Plan”). The 2013 Plan was terminated in July 2021 in connection with the adoption of the 2021 Equity Incentive Plan (“2021 Plan”), which became effective on July 20, 2021, and no further awards will be granted under the 2013 Plan. The 2021 Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options (“NSOs”), stock appreciation rights, restricted stock awards (“RSAs”), performance-based restricted stock units (“PSUs”), restricted stock units (“RSUs”) and other forms of awards to the Company’s employees, directors and consultants, including employees and consultants of the Company’s affiliates. As of December 31, 2022, 5.6 million shares remained available for future issuance under the 2021 Plan. The Company recognized total stock-based compensation expense related to equity incentive awards of $21.7 million and $5.6 million for the years ended December 31, 2022 and 2021, respectively. Stock Options Options are granted with an exercise price equal to the fair value of the shares on the date of grant. The maximum term of options granted under the plan is 10 years from the date of grant. Options generally vest according to a four-year vesting schedule, with 25% of the shares vesting on the first anniversary of the vesting commencement date and the remainder of the shares vesting in equal monthly vesting installments thereafter. The following summarizes the Black-Scholes assumptions used to value the employee options during the periods indicated, as there were no stock options granted during the year ended December 31, 2022: Year Ended December 31, 2021 Stock options: Risk-free interest rate 0.8%-1.3% Weighted-average expected term of the options 6.25 years Expected dividend rate — % Expected volatility 52%-54% The following table summarizes the stock option activity under the 2013 Plan and 2021 Plan (in thousands, except for per share amounts and years): Number of Weighted- Weighted- Aggregate Options outstanding as of December 31, 2020 3,305 $ 3.86 7.21 $ 22,952 Granted 537 18.70 Exercised (1,033) 2.21 Forfeited and cancelled (249) 7.43 Options outstanding as of December 31, 2021 2,560 $ 7.29 5.46 $ 72,875 Granted — — Exercised (922) 4.40 Forfeited and cancelled (366) 15.63 Options outstanding as of December 31, 2022 1,272 $ 6.98 4.96 $ 2,626 Options vested and exercisable as of December 31, 2022 1,104 $ 5.85 4.57 $ 2,626 Aggregate intrinsic value represents the difference between the Company’s estimated fair value of its common stock and the exercise price of outstanding options. The aggregate intrinsic value of stock options exercised was $20.0 million and $33.6 million during the years ended December 31, 2022 and 2021, respectively. As of the years ended December 31, 2022 and 2021, unrecognized stock-based compensation expense related to outstanding unvested stock options that are expected to vest was $1.2 million and $3.2 million, which is expected to be recognized over a weighted-average period of 1.57 years and 2.44 years, respectively. Restricted Stock Awards The fair value of RSAs is determined using the fair value of the Company’s common stock on the date of grant. No RSAs were granted during the year ended December 31, 2022. During the year ended December 31, 2021, the Company granted 0.2 million shares of common stock in the form of RSAs. During the years ended December 31, 2022 and 2021, 100,000 and 51,336 RSAs vested and were released from the Company’s right to repurchase, respectively, and no RSAs were cancelled. As of December 31, 2022 and 2021, the Company had $2.5 million and $3.7 million of unrecognized stock-based compensation related to RSAs, respectively. The weighted average remaining requisite service period was 2.78 years and 3.32 years, respectively. Restricted Stock Units The fair value of RSUs is determined using the closing market price of the Company’s common stock on the date of grant. The RSUs vest over the requisite service period, generally four years, subject to the continuous service of the individual. In March 2022, the Company granted PSUs for 0.6 million shares of common stock. The PSUs vest on the satisfaction of both service-based and performance-based conditions. The PSUs have a one-year performance period based on a revenue goal for fiscal year 2022 that determines the total vestable shares. After the performance period, one-third of the vestable shares will vest, and the remaining vestable shares will vest over a two-year service period. As of December 31, 2022, none of the PSUs have vested or were released. Subsequent to December 31, 2022, it was determined that the Company did not meet revenue targets, and accordingly, the PSUs expired without vesting. The following table summarizes the RSU activity under the 2021 Plan, including the PSUs (in thousands, except for per share amounts): Number of Weighted-average fair value Aggregate Unvested and outstanding as of December 31, 2021 469 $ 47.12 $ 16,781 Granted 3,361 24.62 — Vested (264) 37.43 — Forfeited and cancelled (581) 32.98 — Unvested and outstanding as of December 31, 2022 2,985 $ 25.39 $ 18,864 At December 31, 2022, there was an estimated $56.9 million of total unrecognized stock-based compensation expense related to RSUs and PSUs. These costs will be recognized over a weighted-average period of 3.24 years. CEO Performance Award On May 20, 2022, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) approved a grant to Kiwi Camara, the Company’s Co-Founder and Chief Executive Officer, for a 10-year performance award (the “CEO Performance Award”), the vesting of which is tied solely to achieving specified stock price milestones (“Milestone Prices”), subject to the approval of the Company’s stockholders at the 2022 Annual Meeting of Stockholders. The CEO Performance Award consists of a 10-year option to purchase an aggregate of 4,366,966 shares of the Company’s common stock, representing approximately 7.5% of the total outstanding shares of the Company’s common stock as of the grant date, and vests in six tranches. Each of the six tranches vests only if the applicable Milestone Price is met. The Milestone Prices are met when the average VWAP for any 90-calendar day period during the performance period is equal to or greater than such Milestone Price. “VWAP” means the quotient of (i) the sum of the Daily Total Dollar Volume for the designated period of trading days divided by (ii) the sum of the total trading volume of the Company’s common stock as reported on the primary U.S. exchange on which the Company’s common stock trades for the designated period of trading days, with trading days being the days on which the primary U.S. exchange on which the Company’s common stock trades is open for trading. “Daily Total Dollar Volume” means the product of (i) the closing sales price of the Company’s common stock on a given trading day multiplied by (ii) the corresponding day’s trading volume of the Company’s common stock, in each case as reported on the primary U.S. exchange on which the Company’s common stock trades. For the first tranche to vest, the Company must achieve a Milestone Price of $150 per share, and the next five tranches will only vest if the Company achieves higher Milestone Prices that increase in $150 per share increments up to a final Milestone Price of $900 per share. The exercise price per share subject to the CEO Performance Award is $32.00, which is the greater of (i) the price at which the Company’s common stock was offered to investors in the IPO ($32.00 per share) and (ii) the closing sales price of the Company’s common stock on the grant date. The grant date for accounting purposes of May 25, 2022 was the date on which two full trading sessions elapsed after the filing of the preliminary proxy statement with the SEC. The CEO Performance Award was approved by the Company’s stockholders at the Annual Meeting held on July 12, 2022. Recognition of stock-based compensation expense of all the tranches commenced on the date of grant and is recognized ratably over the expected vesting period of each respective tranche. If the related Milestone Price is achieved earlier than its expected achievement period, then the stock-based compensation expense for that vesting tranche will be accelerated and recorded in the period in which the associated Milestone Price is achieved. The Milestone Price requirement is considered a market condition under Topic 718. The Company estimated the grant date fair value of the CEO Performance Award using Monte Carlo simulations based on the key assumptions for estimating the fair value of the award at the date of grant including volatility of the Company’s common stock price, post-vesting exercise behavior and the derived service period. As of December 31, 2022, no Milestone Prices have been achieved. Total stock-based compensation expense recorded as operating expense for the CEO Performance Award was $4.2 million for the year ended December 31, 2022. As of December 31, 2022, the Company had approximately $40.2 million of total unrecognized stock-based compensation expense remaining under the CEO Performance Award, which will be recognized over a weighted average period of 5.86 years. Employee Stock Purchase Plan In June 2022, the Compensation Committee approved the terms of the Company’s offerings under its 2021 Employee Stock Purchase Plan (“ESPP”). Under the terms of the offering, the Company’s employees can elect to have up to 15% of their annual compensation, up to a maximum of $25,000 per year, withheld to purchase shares of the Company’s common stock for a purchase price equal to 85% of the lesser of the closing fair market value per share of the Company’s common stock on (i) the commencement date of the six-month offering period, or (ii) the respective purchase date. The initial offering period commenced on August 1, 2022 and will end on January 31, 2023 with subsequent six-month offering periods commencing on February 1 st and August 1 st of each year. The Company recognized total stock-based compensation expense related to the ESPP of $0.6 million for the year ended December 31, 2022. No stock-based compensation expense was recognized for the ESPP during the year ended December 31, 2021. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The U.S. and non-U.S. components of loss before income taxes consisted of the following (in thousands): Year Ended December 31, 2022 2021 U.S. $ (71,379) $ (24,553) Non-U.S. 800 290 Loss before income taxes $ (70,579) $ (24,263) The components of the provision for income taxes are as follows (in thousands): Year Ended December 31, 2022 2021 Current Federal $ — $ — State 31 45 Foreign 123 34 Total current 154 79 Deferred Federal 12 — State 3 — Foreign 17 2 Total deferred 32 2 Provision for income taxes $ 186 $ 81 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Significant components of the Company’s deferred tax liabilities and assets are as follows (in thousands): Year Ended December 31, 2022 2021 Deferred tax assets Net operating loss carryforwards $ 38,144 $ 31,046 Capitalized research and development costs 11,018 — Deferred expenses 1,478 2,403 Lease liability 2,785 232 Stock compensation 3,049 1,140 Interest expense carryforwards — 70 Depreciation and amortization 311 145 Credits 142 — Total deferred tax assets 56,927 35,036 Deferred tax liabilities Capitalized service costs (1,162) (1,077) Right-of-use asset (2,564) (225) Total deferred tax liabilities (3,726) (1,302) Net deferred tax asset before valuation allowance 53,201 33,734 Less: valuation allowance (53,216) (33,716) Net deferred tax asset (liability) $ (15) $ 18 The Company has established a valuation allowance due to uncertainties regarding the realization of deferred tax assets based on the Company’s lack of earnings history. During the year ended December 31, 2022, the valuation allowance increased by approximately $19.5 million due to continuing operations. As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately $146.9 million, and $122.2 million, respectively, and state net operating loss carryforwards of approximately $118.4 million, and $86.5 million, respectively, that will begin to expire in 2033, if not utilized prior to that time. Approximately $96.6 million of the U.S. federal net operating losses arose in tax years beginning after December 31, 2017 and have an indefinite carryforward period. Utilization of the net operating loss carryforwards may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986. The annual limitation may result in the expiration of net operating losses and tax credit carryforwards before utilization. The Company’s provision for income taxes attributable to continuing operations differs from the expected tax expense amount computed by applying the statutory federal income tax rate of 21% to loss before income taxes due to the following: Year Ended December 31, 2022 2021 Income tax at U.S. statutory rate 21.0 % 21.0 % Effect of: Change in valuation allowance (27.6) (36.6) State taxes, net of federal benefit 6.0 7.4 Permanent items (0.1) 7.7 Tax credits 0.5 0.0 Other items — 0.1 Income tax provision effective rate (0.2) % (0.4) % The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions, the United Kingdom, and Canada. The Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for years before 2019. Operating losses generated remain open to adjustment until the statute of limitations closes for the tax year in which the operating losses are utilized. The Company is not currently under examination by any tax jurisdictions, but tax years 2019 through 2022 remain open to examination. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities. As of December 31, 2022 and 2021, the Company has recorded no unrecognized tax benefits. The Company’s practice is to recognize interest and penalties related to unrecognized tax benefits outside of income tax expense. During the years ended December 31, 2022 and 2021, the Company did not recognize any interest or penalties related to unrecognized tax benefits. A U.S. shareholder is subject to tax on Global Intangible Low-Taxed Income, or GILTI, earned by certain foreign subsidiaries. Under GAAP, an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. The Company has previously elected to account for GILTI as a period cost in the year the tax is incurred. As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company’s software development expenditures were capitalized and amortized for income tax purposes. |
Defined Contribution Plan
Defined Contribution Plan | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Defined Contribution Plan | Defined Contribution Plan The Company sponsors a defined contribution retirement plan qualifying under Section 401(k) of the Internal Revenue Code of 1986. This plan covers all employees within the United States who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. Beginning in the year ended December 31, 2022, the Company’s contributions to the plan equal 100% of participant contributions up to 1% of the employee’s eligible compensation, and 50% of participant contributions above 1% and up to 6% of the employee’s eligible compensation. The Company made $2.4 million in employer contributions to the plan during the year ended December 31, 2022. The Company did not make any employer contributions to the plan during the year ended December 31, 2021. The Company also engages in a required pension plan in the United Kingdom. As of December 31, 2022 and December 31, 2021, the liability under this plan was immaterial. |
Net Loss Per Share Attributable
Net Loss Per Share Attributable to Common Stockholders | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share Attributable to Common Stockholders | Net Loss Per Share Attributable to Common Stockholders The following table presents calculations for basic and diluted net loss per share (in thousands, except per share amounts): Year Ended December 31, 2022 2021 Net loss $ (70,765) $ (24,344) Less accretion of redeemable convertible preferred stock — (56) Loss applicable to common stockholders basic and diluted (70,765) (24,400) Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 58,753 33,208 Net loss per share attributable to ordinary stockholders, basic and diluted $ (1.20) $ (0.73) The following outstanding shares of common stock equivalents as of the periods presented were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands): As of December 31, 2022 2021 Stock options 1,272 2,581 Unvested restricted stock awards 163 263 Unvested restricted stock units 2,985 469 Total 4,420 3,313 |
Related-Party Transactions
Related-Party Transactions | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related-Party Transactions | Related-Party TransactionsIn October 2018, the Company loaned an officer of the Company $0.2 million, bearing interest at 2.83% per annum for the purpose of exercising stock options. The outstanding amount due under the note was repaid in June 2021. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events On January 19, 2023, the Company committed to a plan to reduce its workforce by approximately 62 employees, representing approximately 9% of the Company’s current global workforce (the “Plan”). The Plan was based on cost-reduction initiatives intended to reduce the Company’s cost structure and accelerate its path to profitability. The Company estimates that it will incur restructuring charges of approximately $0.9 million to $1.1 million in connection with the Plan, consisting of cash expenditures primarily for employee severance and other termination benefits. On January 24, 2023, the Company granted a total of 0.8 million RSUs to employees pursuant to the 2021 Plan. The fair value of the RSU grants was determined based upon the market closing price of the Company’s common stock on the date of grant. The RSUs vest over the requisite service period, subject to the continued service of the individual. The Company expects to recognize aggregate stock-based compensation expense of $5.6 million related to the RSUs over a weighted-average requisite service period of approximately 1.04 years. On January 31, 2023, 0.1 million shares of common stock were purchased under the ESPP at a weighted average price of $7.06 per share, resulting in cash proceeds of $0.9 million. On February 6, 2023, the Company granted a total of 1.8 million RSUs and PSUs to employees pursuant to the 2021 Plan. The fair value of the RSU and PSU grants was determined based upon the market closing price of the Company’s common stock on the date of grant. The RSUs vest over the requisite service period, subject to the continued service of the individual. The PSUs vest on the satisfaction of both service-based and performance-based conditions. The Company expects to recognize aggregate stock-based compensation expense of $15.2 million related to the RSUs and PSUs over a weighted-average requisite service period of approximately 3.30 years. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation and ConsolidationThe accompanying consolidated financial statements have been prepared in accordance with U. S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company. |
Consolidation | All significant intercompany balances and transactions have been eliminated. There are no differences between the net loss and comprehensive loss. |
Use of Estimates | Use of Estimates The preparation of these consolidated financial statements in conformity with GAAP requires the Company to make certain estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses during the reporting period. There is complexity and judgment required in the Company’s process in determining the nature and timing of the satisfaction of performance obligations which affect the amounts of revenue, unbilled receivables and deferred revenue. Estimates are also used for, but not limited to, current expected credit losses, capitalization and useful life of the Company’s capitalized internal-use software development costs, useful lives of assets, fair value of acquired intangible assets, carrying value of goodwill, fair value of contingent consideration, income taxes and deferred tax asset valuation and valuation of the Company’s stock-based awards. Numerous internal and external factors can affect estimates. Actual results could differ from those estimates and such differences could be material to the Company’s consolidated financial position and results of operations. |
Net Loss Per Share Attributable to Common Shareholders | Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Under the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of stock options, restricted stock awards, restricted stock units, and performance-based restricted stock units. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investments acquired with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents, which include the Company’s money market account, are measured at fair value on a recurring basis. |
Accounts Receivable | Accounts Receivable Accounts receivable are recorded and carried at the original invoiced amount less an allowance for credit losses. The Company determines its trade accounts receivable allowances in line with (Topic 326): Measurement of Credit Losses on Financial Instruments |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and trade accounts receivable. The Company maintains its cash and cash equivalent balances in highly rated financial institutions, which at times may exceed federally insured limits or be held in foreign jurisdictions. The Company has not experienced any loss relating to cash and cash equivalents in these accounts. The Company performs periodic credit evaluations of its customers’ financial condition and generally does not require collateral. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company groups its assets and liabilities measured at fair value in a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets, with valuations obtained from readily available pricing sources for market transactions involving identical assets or liabilities; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level of the fair value hierarchy in which the fair value measurement falls is determined by the lowest level input that is significant to the fair value measurement. The Company’s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are considered to approximate their respective fair values due to the short-term nature of such financial instruments. Cash equivalents, primarily consisting of investments in money market funds, are measured at fair value on a recurring basis, and are categorized as Level 1 based on quoted prices in active markets. The carrying value approximates the fair value for these assets and liabilities at December 31, 2022 and 2021. |
Property and Equipment, Net | Property and Equipment, NetProperty and equipment are recorded at cost, less accumulated depreciation. Maintenance, repairs and minor replacements are charged to expense as incurred. Significant renewals and betterments are capitalized. Depreciation on property and equipment, with the exception of leasehold improvements, is recorded using the straight-line method over the estimated useful lives of the assets. Depreciation on leasehold improvements is recorded using the shorter of the lease term or useful life. |
Capitalized Internal-Use Software Development Costs | Capitalized Internal-Use Software Development Costs Costs related to software acquired, developed, or modified solely to meet the Company’s internal requirements, with no plans to market such software at the time of development, are capitalized. Costs incurred during the preliminary planning and evaluation stage of the project and during the post implementation operational stage are expensed as incurred. The Company capitalizes qualifying internal-use software development costs that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Costs incurred for maintenance, minor upgrades and enhancements are expensed. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred. Capitalized costs are included in property and equipment, net on the consolidated balance sheets. These costs are amortized over the estimated useful life of the software, generally four years, on a straight-line basis. Management evaluates the useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The amortization of costs related to the platform applications is included in cost of revenue. |
Purchase Price Allocation, Intangible Assets and Goodwill | Purchase Price Allocation, Intangible Assets and Goodwill The purchase price allocation for business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values. The Company determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this threshold is met, the single asset or group of assets, as applicable, is not a business. If it is not met, the Company determines whether the single asset or group of assets, as applicable, meets the definition of a business. In connection with the Company’s acquisition of legal workflow solutions from Congruity360, LLC (“Congruity”) discussed in Note 9, “Acquisitions, Intangible Assets and Goodwill,” the Company recorded certain intangible assets, including developed technology and customer relationships. Amounts allocated to the acquired intangible assets are being amortized on a straight-line basis over the estimated useful lives. The Company periodically reviews the estimated useful lives and fair values of its identifiable intangible assets, taking into consideration any events or circumstances which might result in a diminished fair value or revised useful life. The excess purchase price over the fair value of assets acquired is recorded as goodwill. The Company tests goodwill for impairment annually during the fourth quarter, or whenever events or changes in circumstances indicate an impairment may have occurred. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, in which case an impairment charge is recorded to goodwill to the extent the carrying value exceeds the fair value, limited to the amount of goodwill. The Company did not recognize any impairment of goodwill for all periods presented. |
Debt Issuance Costs | Debt Issuance Costs The Company records underwriting, legal and other direct costs incurred related to the issuance of the revolving line of credit within other current assets and amortizes these costs to interest expense over the term of the related debt on a straight-line basis, which approximates the effective interest rate method. Upon the extinguishment of the related debt in November 2021, $0.2 million of unamortized capitalized deferred financing costs were recorded to interest expense. There was no amortization expense related to debt issuance costs for the year ended December 31, 2022. |
Leases | Leases The Company determines if an arrangement is or contains a lease at contract inception. The Company presents the operating leases in long-term assets and current and long-term liabilities in the consolidated balance sheets. Finance lease assets are included in property and equipment, net, and finance lease liabilities are presented in current and long-term liabilities on the consolidated balance sheets. Right-of-use assets represent the Company’s right to use an underlying asset over the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company includes any anticipated lease incentives in the determination of lease liabilities. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever an event or change in circumstances indicates that the carrying amount of an asset or group of assets may not be recoverable. The impairment review includes comparison of future cash flows expected to be generated by the asset or group of assets with the associated assets’ carrying value. If the carrying value of the asset or group of assets exceeds its expected future cash flows (undiscounted and without interest charges), an impairment loss is recognized to the extent that the carrying amount of the asset exceeds its fair value. |
Segment Information | Segment Information The Company’s Chief Executive Officer is the chief operating decision maker, who reviews the Company’s financial information presented on a consolidated basis for purposes of allocating resources and evaluating the Company’s financial performance. Accordingly, the Company has determined that it operates in a single reporting segment. |
Advertising | Advertising The Company expenses advertising costs as incurred. Advertising expenses were $3.1 million and $0.4 million for the years ended December 31, 2022 and 2021, respectively. These costs are included in sales and marketing expenses in the consolidated statements of operations and comprehensive loss. |
Cost of Revenue | Cost of Revenue Cost of revenue consists primarily of third-party cloud infrastructure expenses incurred in connection with the Company’s customers’ use of its solutions. Cost of revenue also includes outsourced staffing costs, amortization of internal-use software and personnel costs from employees involved in the delivery of the Company’s solutions. Personnel costs include salaries, benefits, bonuses, stock-based compensation and allocated overhead costs. |
Research and Development | Research and Development Research and development expenses consist primarily of personnel-related costs for the Company’s development team, including salaries, benefits, bonuses, stock-based compensation expenses and allocated overhead costs. Research and development expenses also include contractor or professional services fees, third-party cloud infrastructure expenses incurred in developing the Company’s solution and software services dedicated for use by the Company’s research and development organization. |
Sales And Marketing | Sales and Marketing Sales and marketing expenses consist primarily of personnel-related costs directly associated with the Company’s sales and marketing staff, including salaries, benefits, bonuses, commissions, stock-based compensation and allocated overhead costs. Sales and marketing expenses also include advertising costs and other expenses associated with the Company’s marketing and business development programs. In addition, sales and marketing expenses are comprised of travel-related expenses, software services dedicated for use by the Company’s sales and marketing organizations and outside services contracted for sales and marketing purposes. |
General and Administrative | General and Administrative General and administrative expenses consist of personnel-related costs associated with the Company’s finance, legal, human resources and administrative personnel, including salaries, benefits, bonuses, stock-based compensation and allocated |
Stock-based Compensation | Stock-Based Compensation The Company measures and recognizes compensation expense for all stock-based awards (collectively referred to as stock-based compensation expense), including stock options, restricted stock awards, restricted stock units and performance-based restricted stock units granted to employees, directors and non-employees, based on the estimated fair value of the awards on the date of grant in accordance with ASC Topic 718 Compensation - Stock Compensation (“Topic 718”). The fair value of each stock option granted prior to the IPO was estimated using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the Company to make assumptions and judgments about the inputs used in the calculation, including the expected term, the volatility of the Company’s common stock, risk-free interest rate and expected dividend yield. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. The fair value of stock options granted after the IPO, restricted stock awards, restricted stock units and performance-based restricted stock units is determined using the fair value of the Company’s common stock on the date of grant. Forfeitures are accounted for in the period in which they occur. Stock-based compensation is recognized following the straight-line attribution method over the requisite service period for stock options, restricted stock awards and restricted stock units. Stock-based compensation is recognized under the accelerated attribution method over the requisite service period for performance-based restricted stock units. |
Sales Taxes | Sales Taxes The Company recognizes sales and other taxes collected from customers and subsequently remits the taxes to government authorities. The Company relieves the sales tax payable balances from the consolidated balance sheets as cash is collected from the customer and the taxes are remitted to the appropriate tax authority. |
Contingent Consideration | Contingent Consideration On February 22, 2022, the Company acquired legal workflow solutions from Congruity. As part of the acquisition, the Company entered into a referral agreement in which the Company could be obligated to pay Congruity an additional $2.0 million in the aggregate over a remaining period of 1.96 years. As of December 31, 2022, the estimated fair value of the contingent consideration utilizing a probability weighted scenario analysis model under the scenario-based method was $1.1 million. The short-term and long-term portions of this amount are recorded in accounts payable and other liabilities, respectively, on the consolidated balance sheet. The fair value of the contingent consideration was determined using Level 3 inputs due to estimates for the number and size of referrals, the likelihood of shortfall and any credits that will offset the liability. These estimated inputs reflect management’s best estimate of future results, but these estimates are not observable inputs by a market participant and contain a high degree of uncertainty. The Company could experience significant fluctuations in the fair value of contingent consideration based on actual results. The fair value of this contingent consideration will continue to be revalued on a quarterly basis. Changes in the fair value of the contingent consideration are recorded as operating expense in the consolidated statements of operations and comprehensive loss. As of December 31, 2022, none of the contingent consideration was paid. |
Income Taxes | Income Taxes The Company accounts for income taxes in accordance with the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that are expected to apply to taxable income in the periods in which the deferred tax asset or liability is expected to be realized or settled. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized. All deferred tax assets and liabilities are classified as non-current within the accompanying consolidated balance sheets. The Company recognizes the tax benefit from an uncertain tax position only if it meets the “more likely than not” threshold that the position will be sustained upon examination by the taxing authority, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. The Company includes interest and penalties related to its uncertain tax positions, if any, as part of income tax expense within the accompanying |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08, “ Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ” which intends to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. The Company adopted this guidance as of January 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. |
Revenue Recognition | Revenue is recognized, in an amount that reflects the consideration the Company expects to be entitled to over the term of the agreement, when control of the Company’s solutions are transferred to customers. The Company recognizes revenue through the following five-step framework in accordance with ASC Topic 606, Revenue from Contracts with Customers : (1) Identification of the contract, or contracts, with the customer; (2) Identification of performance obligations in the contract; (3) Determination of the transaction price; (4) Allocation of the transaction price to the performance obligations in the contract; (5) Recognition of revenue when, or as, the Company satisfies a performance obligation. A performance obligation is a promise in a contract to transfer a distinct solution to the customer. The Company identifies performance obligations in its contracts with customers, which primarily include usage-based and subscription solutions. Usage-based solutions include fees based on usage of the Company’s platform or professional services, incurred on a time and materials basis, while subscription solutions represent the purchase of a committed data volume on the Company’s platform over a period of time. The transaction price is determined based on the amount which the Company expects to be entitled to in exchange for providing the promised services to the customer. For contracts that include multiple performance obligations, the transaction price in the contract is allocated to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized over time as performance obligations are satisfied. Variable consideration is evaluated on a contract-by-contract basis, and a constraint is applied using the facts and circumstances of the contract when applicable. On a limited basis, the Company enters into contracts whereby the consideration payable is contingent upon the conclusion of the legal matter. The Company does not recognize the revenue related to these contracts until the legal matter is resolved. Such amounts recognized have been immaterial to date. The Company’s software contracts do not allow the customer to take possession of the software supporting the cloud-based solution. Customers are not entitled to any refunds. The Company’s arrangements do not contain general rights of return. However, credits may be issued on a case-by-case basis. Amounts that have been invoiced are recorded in accounts receivable and in revenue or deferred revenue depending on whether the revenue recognition criteria have been met. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Schedule of Property and Equipment Useful Life | The estimated useful life of each asset category is as follows: Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or 5 years Computer equipment 2 years Property and equipment consist of the following (in thousands): December 31, December 31, Computer equipment $ 5,089 $ 3,079 Capitalized internal-use software 6,707 5,168 Leasehold improvements 467 111 Furniture 1,185 649 Total property and equipment 13,448 9,007 Less: accumulated depreciation and amortization (5,941) (3,672) Property and equipment, net $ 7,507 $ 5,335 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment Useful Life | The estimated useful life of each asset category is as follows: Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or 5 years Computer equipment 2 years Property and equipment consist of the following (in thousands): December 31, December 31, Computer equipment $ 5,089 $ 3,079 Capitalized internal-use software 6,707 5,168 Leasehold improvements 467 111 Furniture 1,185 649 Total property and equipment 13,448 9,007 Less: accumulated depreciation and amortization (5,941) (3,672) Property and equipment, net $ 7,507 $ 5,335 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Schedule of Lease Cost | The cost of leases recorded in the accompanying consolidated statements of operations and comprehensive loss were as follows (in thousands): Year Ended Operating lease expense $ 1,784 Finance lease expense Amortization expense 56 Interest on lease liability 7 Short-term lease expense Lease expense 227 Total lease cost $ 2,074 |
Schedule of Supplemental Balance Sheet and Cash Flow Information | The Company’s operating and finance right-of-use assets and lease liabilities are as follows (in thousands): Leases Classification December 31, 2022 Assets Operating lease assets Operating right-of-use asset, net of accumulated amortization $ 9,824 Finance lease assets Property and equipment, net of accumulated depreciation 217 Total leased assets $ 10,041 Liabilities Current Operating leases Operating lease liability, current $ 1,902 Finance leases Finance lease liability, current 39 Non-current Operating leases Operating lease liability, non-current 8,770 Finance leases Finance lease liability, non-current 199 Total lease liabilities $ 10,910 Supplemental cash flow information related to leases as of December 31, 2022 was as follows (in thousands) : Cash paid for operating lease liabilities $ 782 Cash paid for financing lease liabilities $ 42 Right-of-use assets obtained in exchange for operating lease liabilities $ 10,935 The weighted average remaining lease term and discount rate as of December 31, 2022 are as follows: Weighted Average Remaining Lease Term Operating leases 5.43 years Finance leases 5.59 years Weighted Average Discount Rate Operating leases 5.00 % Finance leases 5.00 % |
Schedule of Future Minimum Payments, Operating Lease | Future minimum payments required under operating leases, by year and in aggregate, that have initial or remaining non-cancellable lease terms in excess of one year, are as follows (in thousands): Year Ended Operating Finance 2023 $ 2,391 $ 47 2024 2,036 47 2025 2,098 47 2026 2,162 47 2027 2,229 47 Thereafter 1,333 28 Total $ 12,249 $ 263 |
Schedule of Future Minimum Payments, Finance Lease | Future minimum payments required under operating leases, by year and in aggregate, that have initial or remaining non-cancellable lease terms in excess of one year, are as follows (in thousands): Year Ended Operating Finance 2023 $ 2,391 $ 47 2024 2,036 47 2025 2,098 47 2026 2,162 47 2027 2,229 47 Thereafter 1,333 28 Total $ 12,249 $ 263 |
Operating Segment and Geograp_2
Operating Segment and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Disaggregation of Revenue | The Company determines the location of revenue using the billing address of each customer. The following table sets forth revenue by geographic area (in thousands): Year Ended 2022 2021 United States $ 126,504 $ 107,084 All other countries 8,686 7,258 Total revenue $ 135,190 $ 114,342 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contractual Obligation, Fiscal Year Maturity | These commitments, which relate mainly to hosting agreements as well as computer software licenses used to facilitate company operations, are as follows (in thousands): Purchase obligations December 31, 2022 2023 $ 18,966 2024 18,434 2025 18,135 Thereafter — Total $ 55,535 |
Acquisitions, Intangible Asse_2
Acquisitions, Intangible Assets and Goodwill (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Assets Acquired and Liabilities Assumed | The aggregate purchase consideration and estimated fair values of the assets acquired and liabilities assumed at the date of acquisition were as follows (in thousands): Fair Value Fair value of net assets acquired: Net tangible assets (liabilities) $ (395) Developed technology 900 Customer relationships 300 Goodwill 5,898 Total fair value of net assets acquired $ 6,703 |
Schedule of Acquired Intangible Assets | Intangible assets, net consisted of the following (in thousands): December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Developed technology $ 900 $ (153) $ 747 5 years Customer relationships 300 (85) 215 3 years Total $ 1,200 $ (238) $ 962 |
Schedule of Future Amortization Expense | As of December 31, 2022, future amortization expense by year is expected to be as follows (in thousands): Amount 2023 $ 280 2024 280 2025 195 2026 180 2027 27 Total $ 962 |
Schedule of Goodwill | The changes in the carrying amount of goodwill during the year ended December 31, 2022 were as follows (in thousands): Amount Balance as of December 31, 2021 $ — 2022 acquisition 5,898 Total $ 5,898 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Black-Scholes Assumptions | The following summarizes the Black-Scholes assumptions used to value the employee options during the periods indicated, as there were no stock options granted during the year ended December 31, 2022: Year Ended December 31, 2021 Stock options: Risk-free interest rate 0.8%-1.3% Weighted-average expected term of the options 6.25 years Expected dividend rate — % Expected volatility 52%-54% |
Schedule of Stock Option Activity | The following table summarizes the stock option activity under the 2013 Plan and 2021 Plan (in thousands, except for per share amounts and years): Number of Weighted- Weighted- Aggregate Options outstanding as of December 31, 2020 3,305 $ 3.86 7.21 $ 22,952 Granted 537 18.70 Exercised (1,033) 2.21 Forfeited and cancelled (249) 7.43 Options outstanding as of December 31, 2021 2,560 $ 7.29 5.46 $ 72,875 Granted — — Exercised (922) 4.40 Forfeited and cancelled (366) 15.63 Options outstanding as of December 31, 2022 1,272 $ 6.98 4.96 $ 2,626 Options vested and exercisable as of December 31, 2022 1,104 $ 5.85 4.57 $ 2,626 |
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity | The following table summarizes the RSU activity under the 2021 Plan, including the PSUs (in thousands, except for per share amounts): Number of Weighted-average fair value Aggregate Unvested and outstanding as of December 31, 2021 469 $ 47.12 $ 16,781 Granted 3,361 24.62 — Vested (264) 37.43 — Forfeited and cancelled (581) 32.98 — Unvested and outstanding as of December 31, 2022 2,985 $ 25.39 $ 18,864 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income before Income Tax, Domestic and Foreign | The U.S. and non-U.S. components of loss before income taxes consisted of the following (in thousands): Year Ended December 31, 2022 2021 U.S. $ (71,379) $ (24,553) Non-U.S. 800 290 Loss before income taxes $ (70,579) $ (24,263) |
Schedule of Components of Income Tax Expense (Benefit) | The components of the provision for income taxes are as follows (in thousands): Year Ended December 31, 2022 2021 Current Federal $ — $ — State 31 45 Foreign 123 34 Total current 154 79 Deferred Federal 12 — State 3 — Foreign 17 2 Total deferred 32 2 Provision for income taxes $ 186 $ 81 |
Schedule of Deferred Tax Assets and Liabilities | Significant components of the Company’s deferred tax liabilities and assets are as follows (in thousands): Year Ended December 31, 2022 2021 Deferred tax assets Net operating loss carryforwards $ 38,144 $ 31,046 Capitalized research and development costs 11,018 — Deferred expenses 1,478 2,403 Lease liability 2,785 232 Stock compensation 3,049 1,140 Interest expense carryforwards — 70 Depreciation and amortization 311 145 Credits 142 — Total deferred tax assets 56,927 35,036 Deferred tax liabilities Capitalized service costs (1,162) (1,077) Right-of-use asset (2,564) (225) Total deferred tax liabilities (3,726) (1,302) Net deferred tax asset before valuation allowance 53,201 33,734 Less: valuation allowance (53,216) (33,716) Net deferred tax asset (liability) $ (15) $ 18 |
Schedule of Effective Income Tax Rate Reconciliation | The Company’s provision for income taxes attributable to continuing operations differs from the expected tax expense amount computed by applying the statutory federal income tax rate of 21% to loss before income taxes due to the following: Year Ended December 31, 2022 2021 Income tax at U.S. statutory rate 21.0 % 21.0 % Effect of: Change in valuation allowance (27.6) (36.6) State taxes, net of federal benefit 6.0 7.4 Permanent items (0.1) 7.7 Tax credits 0.5 0.0 Other items — 0.1 Income tax provision effective rate (0.2) % (0.4) % |
Net Loss Per Share Attributab_2
Net Loss Per Share Attributable to Common Stockholders (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Net Loss Per Share, Basic and Diluted | The following table presents calculations for basic and diluted net loss per share (in thousands, except per share amounts): Year Ended December 31, 2022 2021 Net loss $ (70,765) $ (24,344) Less accretion of redeemable convertible preferred stock — (56) Loss applicable to common stockholders basic and diluted (70,765) (24,400) Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 58,753 33,208 Net loss per share attributable to ordinary stockholders, basic and diluted $ (1.20) $ (0.73) |
Schedule of Securities Excluded from Computation of Net Loss Per Share | The following outstanding shares of common stock equivalents as of the periods presented were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands): As of December 31, 2022 2021 Stock options 1,272 2,581 Unvested restricted stock awards 163 263 Unvested restricted stock units 2,985 469 Total 4,420 3,313 |
Organization and Nature of Op_2
Organization and Nature of Operations (Details) - USD ($) $ / shares in Units, $ in Millions | Sep. 17, 2021 | Jul. 23, 2021 | Jul. 21, 2021 |
IPO | |||
Class of Stock [Line Items] | |||
Underwriting discounts and commissions | $ 16.8 | ||
Stock offering expenses | $ 3.7 | ||
Over-Allotment Option | |||
Class of Stock [Line Items] | |||
Shares issued and sold (in shares) | 200,000 | ||
Secondary Public Offering | |||
Class of Stock [Line Items] | |||
Stock offering expenses | $ 0.1 | ||
Common stock | |||
Class of Stock [Line Items] | |||
Shares converted (in shares) | 35,793,483 | ||
Common stock | IPO | |||
Class of Stock [Line Items] | |||
Shares issued and sold (in shares) | 7,500,000 | ||
Public offering price per share (in dollars per share) | $ 32 | $ 32 | |
Proceeds from public offering | $ 223.2 | ||
Common stock | Over-Allotment Option | |||
Class of Stock [Line Items] | |||
Shares issued and sold (in shares) | 550,000 | 500,000 | |
Common stock | Secondary Public Offering | |||
Class of Stock [Line Items] | |||
Shares issued and sold (in shares) | 6,050,000 | ||
Public offering price per share (in dollars per share) | $ 53 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Allowance for Credit Loss (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | ||
Credit loss provision | $ 1.4 | |
Credit loss, write-off | 1 | |
Credit loss, recovery | 0.1 | |
Allowance for credit loss | $ 1.5 | $ 1.2 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Property and Equipment Useful Life (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Furniture and fixtures | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 5 years |
Leasehold improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 5 years |
Computer equipment | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 2 years |
Capitalized internal-use software | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 4 years |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Narrative (Details) | 1 Months Ended | 12 Months Ended | ||
Nov. 30, 2021 USD ($) | Dec. 31, 2022 USD ($) segment | Dec. 31, 2021 USD ($) | Feb. 22, 2022 USD ($) | |
Income Tax Contingency [Line Items] | ||||
Extinguished debt, deferred financing costs | $ 200,000 | |||
Amortization of debt issuance costs | $ 0 | |||
Number of reportable segments | segment | 1 | |||
Advertising expense | $ 3,100,000 | $ 400,000 | ||
Unrecognized tax benefits, penalties and interest recognized | 0 | 0 | ||
Unrecognized tax benefits, penalties and interest accrued | 0 | $ 0 | ||
Congruity360, LLC | ||||
Income Tax Contingency [Line Items] | ||||
Contingent consideration | $ 2,000,000 | |||
Contingent consideration, liability, term | 1 year 11 months 15 days | |||
Congruity360, LLC | Fair Value | ||||
Income Tax Contingency [Line Items] | ||||
Contingent consideration | $ 1,100,000 |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Deferred revenue | $ 2,200 | $ 1,600 | |
Deferred revenue recognized | $ 2,200 | 1,600 | |
Current deferred revenue | 4,100 | 2,175 | |
Contract assets | 2,000 | $ 3,200 | |
Remaining performance obligation | 21,500 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |||
Disaggregation of Revenue [Line Items] | |||
Remaining performance obligation | $ 13,400 | ||
Remaining performance obligation, expected timing of satisfaction | 12 months | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |||
Disaggregation of Revenue [Line Items] | |||
Remaining performance obligation, expected timing of satisfaction | 12 months | ||
Revenue Benchmark | Product Concentration Risk | Usage Based Revenue | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk percentage | 89% | 89% | |
Revenue Benchmark | Product Concentration Risk | Subscription Revenue | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk percentage | 11% | 11% |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 13,448 | $ 9,007 |
Less: accumulated depreciation and amortization | (5,941) | (3,672) |
Property and equipment, net | 7,507 | 5,335 |
Computer equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 5,089 | 3,079 |
Capitalized internal-use software | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 6,707 | 5,168 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 467 | 111 |
Furniture | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 1,185 | $ 649 |
Property and Equipment - Narrat
Property and Equipment - Narrative (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Abstract] | ||
Depreciation | $ 2,700,000 | $ 1,600,000 |
Capitalized internal-use software, amortization | 1,200,000 | 700,000 |
Capitalized internal-use software | 1,500,000 | 1,900,000 |
Capitalized internal-use software, unamortized | 4,300,000 | 4,000,000 |
Capitalized internal-use software, impairment | $ 0 | $ 0 |
Leases - Narrative (Details)
Leases - Narrative (Details) | 12 Months Ended | |
Dec. 31, 2022 USD ($) lease | Dec. 31, 2021 USD ($) | |
Lessee, Lease, Description [Line Items] | ||
Number of short term leases | lease | 1 | |
Unoccupied lease expense | $ | $ 1,100,000 | $ 0 |
NEW YORK | ||
Lessee, Lease, Description [Line Items] | ||
Operating lease, extension term | 6 months |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Leases [Abstract] | |
Operating lease expense | $ 1,784 |
Finance lease expense | |
Amortization expense | 56 |
Interest on lease liability | 7 |
Short-term lease expense | |
Lease expense | 227 |
Total lease cost | $ 2,074 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet and Cash Flow Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Assets | ||
Operating lease assets | $ 9,824 | $ 864 |
Finance lease assets | 217 | |
Total leased assets | $ 10,041 | |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Property and equipment, net | |
Current | ||
Operating leases | $ 1,902 | 890 |
Finance leases | 39 | 99 |
Non-current | ||
Operating leases | 8,770 | 0 |
Finance leases | 199 | 0 |
Total lease liabilities | 10,910 | |
Cash Flow, Lessee | ||
Cash paid for operating lease liabilities | 782 | |
Cash paid for financing lease liabilities | 42 | $ 112 |
Right-of-use assets obtained in exchange for operating lease liabilities | $ 10,935 | |
Weighted Average Remaining Lease Term | ||
Operating leases | 5 years 5 months 4 days | |
Finance leases | 5 years 7 months 2 days | |
Weighted Average Discount Rate | ||
Operating leases | 5% | |
Finance leases | 5% |
Leases - Future Payments, Opera
Leases - Future Payments, Operating and Financing Leases (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Operating Leases | |
2023 | $ 2,391 |
2024 | 2,036 |
2025 | 2,098 |
2026 | 2,162 |
2027 | 2,229 |
Thereafter | 1,333 |
Total | 12,249 |
Finance Leases | |
2023 | 47 |
2024 | 47 |
2025 | 47 |
2026 | 47 |
2027 | 47 |
Thereafter | 28 |
Total | $ 263 |
Operating Segment and Geograp_3
Operating Segment and Geographic Information (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 USD ($) segment | Dec. 31, 2021 USD ($) | |
Disaggregation of Revenue [Line Items] | ||
Number of reportable segments | segment | 1 | |
Total revenue | $ 135,190 | $ 114,342 |
United States | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 126,504 | 107,084 |
All other countries | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 8,686 | $ 7,258 |
Debt and Related Warrants (Deta
Debt and Related Warrants (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
Nov. 30, 2021 | Oct. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Nov. 30, 2018 | |
Line of Credit Facility [Line Items] | ||||||
Proceeds from exercise of warrants | $ 100,000 | $ 0 | $ 146,000 | |||
Extinguished debt, deferred financing costs | $ 200,000 | |||||
Amortization of debt issuance costs | 0 | |||||
Other Operating Expense | ||||||
Line of Credit Facility [Line Items] | ||||||
Extinguished debt, deferred financing costs | $ 200,000 | |||||
Loan and Security Agreement | Revolving Credit Facility | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit facility, maximum borrowing capacity | $ 18,000,000 | |||||
Long-term debt, gross | $ 0 | |||||
Second Amended and Restated Loan and Security Agreement | ||||||
Line of Credit Facility [Line Items] | ||||||
Warrants granted to purchase (in shares) | 49,869 | |||||
Warrants outstanding, term | 10 years | |||||
Second Amended and Restated Loan and Security Agreement | Minimum | ||||||
Line of Credit Facility [Line Items] | ||||||
Exercise price of warrants or rights (in dollars per share) | $ 0.525 | |||||
Second Amended and Restated Loan and Security Agreement | Maximum | ||||||
Line of Credit Facility [Line Items] | ||||||
Exercise price of warrants or rights (in dollars per share) | $ 10.80 | |||||
Second Amended and Restated Loan and Security Agreement | Revolving Credit Facility | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit facility, maximum borrowing capacity | $ 40,000,000 | |||||
Debt instrument, covenant, liquidity amount | $ 5,000,000 | |||||
Debt instrument, covenant, adjusted EBITDA burn, term | 6 months | |||||
Debt instrument, covenant, adjusted EBITDA burn, amount outstanding | $ 18,000,000 | |||||
Debt instrument, basis spread on variable rate | 0.25% | |||||
Unused commitment fee percentage | 0.25% | |||||
Second Amended and Restated Loan and Security Agreement | Revolving Credit Facility | LIBOR | ||||||
Line of Credit Facility [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 2.50% |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Minimum | |
Other Commitments [Line Items] | |
Term of contract | 1 year |
Maximum | |
Other Commitments [Line Items] | |
Term of contract | 3 years |
Commitments and Contingencies_2
Commitments and Contingencies - Contractual Obligation, Maturity (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2023 | $ 18,966 |
2024 | 18,434 |
2025 | 18,135 |
Thereafter | 0 |
Total | $ 55,535 |
Acquisitions, Intangible Asse_3
Acquisitions, Intangible Assets and Goodwill - Congruity Acquisition (Details) - Congruity360, LLC - USD ($) $ in Millions | 12 Months Ended | |
Feb. 22, 2022 | Dec. 31, 2022 | |
Business Acquisition [Line Items] | ||
Payments to acquire business | $ 6.1 | |
Holdback funds | 0.8 | |
Contingent consideration | 2 | |
Consideration transferred, liabilities incurred | $ 0.5 | |
Business acquisition, transaction costs | $ 0.1 | |
Fair Value | ||
Business Acquisition [Line Items] | ||
Contingent consideration | $ 1.1 |
Acquisitions, Intangible Asse_4
Acquisitions, Intangible Assets and Goodwill - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Feb. 22, 2022 | Dec. 31, 2021 |
Business Acquisition [Line Items] | |||
Goodwill | $ 5,898 | $ 0 | |
Congruity360, LLC | |||
Business Acquisition [Line Items] | |||
Net tangible assets (liabilities) | $ (395) | ||
Goodwill | 5,898 | ||
Total fair value of net assets acquired | 6,703 | ||
Congruity360, LLC | Developed technology | |||
Business Acquisition [Line Items] | |||
Intangible assets | 900 | ||
Congruity360, LLC | Customer relationships | |||
Business Acquisition [Line Items] | |||
Intangible assets | $ 300 |
Acquisitions, Intangible Asse_5
Acquisitions, Intangible Assets and Goodwill - Acquired Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||
Net Carrying Amount | $ 962 | $ 0 |
Congruity360, LLC | ||
Business Acquisition [Line Items] | ||
Gross Carrying Amount | 1,200 | |
Accumulated Amortization | (238) | |
Net Carrying Amount | 962 | |
Congruity360, LLC | Developed technology | ||
Business Acquisition [Line Items] | ||
Gross Carrying Amount | 900 | |
Accumulated Amortization | (153) | |
Net Carrying Amount | $ 747 | |
Amortization Period | 5 years | |
Congruity360, LLC | Customer relationships | ||
Business Acquisition [Line Items] | ||
Gross Carrying Amount | $ 300 | |
Accumulated Amortization | (85) | |
Net Carrying Amount | $ 215 | |
Amortization Period | 3 years |
Acquisitions, Intangible Asse_6
Acquisitions, Intangible Assets and Goodwill - Intangible Assets Narrative (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Business Combination and Asset Acquisition [Abstract] | |
Intangible asset, amortization expense | $ 0.2 |
Acquisitions, Intangible Asse_7
Acquisitions, Intangible Assets and Goodwill - Future Amortization Expense (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Business Combination and Asset Acquisition [Abstract] | |
2023 | $ 280 |
2024 | 280 |
2025 | 195 |
2026 | 180 |
2027 | 27 |
Total | $ 962 |
Acquisitions, Intangible Asse_8
Acquisitions, Intangible Assets and Goodwill - Goodwill (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | $ 0 |
2022 acquisition | 5,898 |
Goodwill, Ending Balance | $ 5,898 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 12 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Aggregate intrinsic value of options exercised | $ 20 | $ 33.6 | |
Unrecognized compensation costs | $ 1.2 | 3.2 | |
Equity Incentive Plans | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Shares available for future issuance (in shares) | 5,600,000 | ||
Stock-based compensation expense | $ 21.7 | $ 5.6 | |
Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Term of options granted | 10 years | ||
Vesting period | 4 years | ||
Percentage of awards vesting each year | 25% | ||
Weighted-average expected recognition period | 1 year 6 months 25 days | 2 years 5 months 8 days | |
Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation costs | $ 2.5 | $ 3.7 | |
Weighted-average expected recognition period | 2 years 9 months 10 days | 3 years 3 months 25 days | |
Grants in period (in shares) | 0 | 200,000 | |
Awards vested and released from right to repurchase (in shares) | 100,000 | 51,336 | |
Awards cancelled (in shares) | 0 | 0 | |
Restricted Stock Units (RSUs) and Performance Shares (PSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted-average expected recognition period | 3 years 2 months 26 days | ||
Grants in period (in shares) | 3,361,000 | ||
Awards vested and released from right to repurchase (in shares) | 264,000 | ||
Unrecognized stock-based compensation | $ 56.9 | ||
Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 4 years | ||
Performance Shares | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Percentage of awards vesting each year | 33.33% | ||
Grants in period (in shares) | 600,000 | ||
Performance period | 1 year | ||
Requisite service period | 2 years |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Black-Scholes Assumptions (Details) - Stock options | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Risk-free interest rate, minimum | 0.80% |
Risk-free interest rate, maximum | 1.30% |
Weighted-average expected term of the options | 6 years 3 months |
Expected dividend rate | 0% |
Expected volatility, minimum | 52% |
Expected volatility, maximum | 54% |
Stock-Based Compensation - Sc_2
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Number of shares | |||
Options outstanding at beginning of period (in shares) | 2,560 | 3,305 | |
Options granted (in shares) | 0 | 537 | |
Options exercised (in shares) | (922) | (1,033) | |
Options forfeited and cancelled (in shares) | (366) | (249) | |
Options outstanding at end of period (in shares) | 1,272 | 2,560 | 3,305 |
Options vested and exercisable (in shares) | 1,104 | ||
Weighted-average exercise price per share | |||
Weighted-average exercise price of options outstanding at beginning of period (in USD per share) | $ 7.29 | $ 3.86 | |
Weighted-average exercise price of options granted (in USD per share) | 0 | 18.70 | |
Weighted-average exercise price of options exercised (in USD per share) | 4.40 | 2.21 | |
Weighted-average exercise price of options forfeited and cancelled (in USD per share) | 15.63 | 7.43 | |
Weighted-average exercise price of options outstanding at end of period (in USD per share) | 6.98 | $ 7.29 | $ 3.86 |
Weighted-average exercise price of options vested and exercisable (in USD per share) | $ 5.85 | ||
Weighted-average remaining contractual life of options outstanding (in years) | 4 years 11 months 15 days | 5 years 5 months 15 days | 7 years 2 months 15 days |
Weighted-average remaining contractual life of options vested and exercisable (in years) | 4 years 6 months 25 days | ||
Aggregate intrinsic value of options outstanding | $ 2,626 | $ 72,875 | $ 22,952 |
Aggregate intrinsic value of options vested and exercisable | $ 2,626 |
Stock-Based Compensation - Sc_3
Stock-Based Compensation - Schedule of Restricted Stock Unity Activity (Details) - Restricted Stock Units (RSUs) and Performance Shares (PSUs) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Number of Shares | ||
Unvested and outstanding, beginning balance (in shares) | 469 | |
Granted (in shares) | 3,361 | |
Vested (in shares) | (264) | |
Forfeited and cancelled (in shares) | (581) | |
Unvested and outstanding, ending balance (in shares) | 2,985 | 469 |
Weighted-average fair value | ||
Unvested and outstanding, beginning balance (in dollars per share) | $ 47.12 | |
Granted (in dollars per share) | 24.62 | |
Vested (in dollars per share) | 37.43 | |
Forfeited and cancelled (in dollars per share) | 32.98 | |
Unvested and outstanding, ending balance (in dollars per share) | $ 25.39 | $ 47.12 |
Aggregate intrinsic value | ||
Unvested and outstanding as of December 31, 2021 | $ 18,864 | $ 16,781 |
Unvested and outstanding as of December 31, 2022 | $ 18,864 | $ 16,781 |
Stock-Based Compensation - CEO
Stock-Based Compensation - CEO Performance Award (Details) $ / shares in Units, $ in Millions | 12 Months Ended | |||
May 20, 2022 tranche $ / shares shares | Dec. 31, 2022 USD ($) | Jul. 23, 2021 $ / shares | Jul. 21, 2021 $ / shares | |
Common stock | IPO | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Public offering price per share (in dollars per share) | $ 32 | $ 32 | ||
CEO Performance Award | CEO Performance Award | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Option to purchase outstanding shares, period | 10 years | |||
Term of options granted | 10 years | |||
Option to purchase common shares (in shares) | shares | 4,366,966 | |||
Option to purchase common shares, percent | 7.50% | |||
Number of tranches | tranche | 6 | |||
Milestone price VWAP threshold, period | 90 days | |||
Share price (in dollars per share) | $ 32 | |||
Stock-based compensation expense | $ | $ 4.2 | |||
Unrecognized stock-based compensation | $ | $ 40.2 | |||
Weighted-average expected recognition period | 5 years 10 months 9 days | |||
CEO Performance Award | CEO Performance Award | Tranche One | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting threshold, milestone price (in dollars per share) | 150 | |||
CEO Performance Award | CEO Performance Award | Tranche Two Through Six | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting threshold, incremental increase in milestone price (in dollars per share) | 150 | |||
CEO Performance Award | CEO Performance Award | Tranche Six | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting threshold, milestone price (in dollars per share) | $ 900 |
Stock-Based Compensation - Empl
Stock-Based Compensation - Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - USD ($) | 1 Months Ended | 12 Months Ended | |
Jun. 30, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Maximum contribution rate | 15% | ||
Maximum contribution amount | $ 25,000 | ||
Purchase price of common stock, percent | 85% | ||
ESPP purchase period | 6 months | ||
Stock-based compensation expense | $ 600,000 | $ 0 |
Income Taxes - Income before In
Income Taxes - Income before Income Tax (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
U.S. | $ (71,379) | $ (24,553) |
Non-U.S. | 800 | 290 |
Loss from operations before income taxes | $ (70,579) | $ (24,263) |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Tax Provisions (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Current | ||
Federal | $ 0 | $ 0 |
State | 31 | 45 |
Foreign | 123 | 34 |
Total current | 154 | 79 |
Deferred | ||
Federal | 12 | 0 |
State | 3 | 0 |
Foreign | 17 | 2 |
Total deferred | 32 | 2 |
Provision for income taxes | $ 186 | $ 81 |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred tax assets | ||
Net operating loss carryforwards | $ 38,144 | $ 31,046 |
Capitalized research and development costs | 11,018 | 0 |
Deferred expenses | 1,478 | 2,403 |
Lease liability | 2,785 | 232 |
Stock compensation | 3,049 | 1,140 |
Interest expense carryforwards | 0 | 70 |
Depreciation and amortization | 311 | 145 |
Credits | 142 | 0 |
Total deferred tax assets | 56,927 | 35,036 |
Deferred tax liabilities | ||
Capitalized service costs | (1,162) | (1,077) |
Right-of-use asset | (2,564) | (225) |
Total deferred tax liabilities | (3,726) | (1,302) |
Net deferred tax asset before valuation allowance | 53,201 | 33,734 |
Less: valuation allowance | (53,216) | (33,716) |
Net deferred tax asset (liability) | $ (15) | |
Net deferred tax asset (liability) | $ 18 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Contingency [Line Items] | ||
Increase in valuation allowance | $ 19,500,000 | |
Unrecognized tax benefits | 0 | $ 0 |
Unrecognized tax benefits, penalties and interest | 0 | 0 |
Federal | ||
Income Tax Contingency [Line Items] | ||
Operating loss carryforward | 146,900,000 | 122,200,000 |
Federal | Tax Years Beginning After December 31, 2017 | ||
Income Tax Contingency [Line Items] | ||
Operating loss carryforward | 96,600,000 | |
State | ||
Income Tax Contingency [Line Items] | ||
Operating loss carryforward | $ 118,400,000 | $ 86,500,000 |
Income Taxes - Effective Tax Ra
Income Taxes - Effective Tax Rate Reconciliation (Details) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Income tax at U.S. statutory rate | 21% | 21% |
Effect of: | ||
Change in valuation allowance | (27.60%) | (36.60%) |
State taxes, net of federal benefit | 6% | 7.40% |
Permanent items | (0.10%) | 7.70% |
Tax credits | 0.50% | 0% |
Other items | 0% | 0.10% |
Income tax provision effective rate | (0.20%) | (0.40%) |
Defined Contribution Plan (Deta
Defined Contribution Plan (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Contribution Plan Disclosure [Line Items] | ||
Employer contributions | $ 2,400,000 | $ 0 |
Maximum annual contributions per employee, percent | 100% | |
Percent contribution by employee's eligible compensation | 1% | |
Employer matching contribution, percent of match | 50% | |
Maximum | ||
Defined Contribution Plan Disclosure [Line Items] | ||
Percent contribution by employee's eligible compensation | 6% |
Net Loss Per Share Attributab_3
Net Loss Per Share Attributable to Common Stockholders - Computation Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Earnings Per Share [Abstract] | ||
Net loss | $ (70,765) | $ (24,344) |
Less accretion of redeemable convertible preferred stock | 0 | (56) |
Net loss attributable to common stockholders | (70,765) | (24,400) |
Net loss attributable to common stockholders | $ (70,765) | $ (24,400) |
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 58,753 | 33,208 |
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 58,753 | 33,208 |
Net loss per share attributable to ordinary stockholders, basic (in dollars per share) | $ (1.20) | $ (0.73) |
Net loss per share attributable to ordinary stockholders, diluted (in dollars per share) | $ (1.20) | $ (0.73) |
Net Loss Per Share Attributab_4
Net Loss Per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares shares in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount | 4,420 | 3,313 |
Stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount | 1,272 | 2,581 |
Unvested restricted stock awards | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount | 163 | 263 |
Unvested restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount | 2,985 | 469 |
Related-Party Transactions (Det
Related-Party Transactions (Details) - Officer $ in Millions | 1 Months Ended |
Oct. 31, 2018 USD ($) | |
Related Party Transaction [Line Items] | |
Loan to related party | $ 0.2 |
Interest rate on loan to related party | 2.83% |
Subsequent Events (Details)
Subsequent Events (Details) $ / shares in Units, shares in Millions, $ in Millions | Feb. 06, 2023 USD ($) shares | Jan. 31, 2023 USD ($) $ / shares shares | Jan. 24, 2023 USD ($) shares | Jan. 19, 2023 USD ($) employee |
Minimum | Forecast | ||||
Subsequent Event [Line Items] | ||||
Restructuring charges | $ 1.1 | |||
Maximum | Forecast | ||||
Subsequent Event [Line Items] | ||||
Restructuring charges | $ 0.9 | |||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Number of employees | employee | 62 | |||
Percentage of company workforce | 9% | |||
Subsequent Event | Unvested restricted stock units | ||||
Subsequent Event [Line Items] | ||||
Grants in period (in shares) | shares | 0.8 | |||
Unrecognized stock-based compensation | $ 5.6 | |||
Weighted-average expected recognition period | 1 year 14 days | |||
Subsequent Event | Common stock | ||||
Subsequent Event [Line Items] | ||||
Issuance of shares, employee stock ownership plan (in shares) | shares | 0.1 | |||
Shares issued, price per share (in dollars per shares) | $ / shares | $ 7.06 | |||
Issuance of shares, employee stock ownership plan value | $ 0.9 | |||
Subsequent Event | Restricted Stock Units (RSUs) and Performance-Based Restricted Stock Units (PSUs) | ||||
Subsequent Event [Line Items] | ||||
Grants in period (in shares) | shares | 1.8 | |||
Unrecognized stock-based compensation | $ 15.2 | |||
Weighted-average expected recognition period | 3 years 3 months 18 days |